| Saham Orang Dalam | 25,612,643 shares |
| Orang Dalam Sejati | 38 |
Skor Sentimen Orang Dalam
Skor Sentimen Orang Dalam mengidentifikasi perusahaan yang dibeli oleh orang dalam korporat.
Ini adalah hasil dari model kuantitatif multifaktor yang canggih yang mengidentifikasi perusahaan dengan tingkat akumulasi internal tertinggi. Model penilaian ini menggunakan kombinasi dari jumlah bersih orang dalam yang membeli dalam 90 hari sebelumnya, total saham yang dibeli sebagai persentase dari jumlah saham yang beredar, dan total saham yang dimiliki oleh orang dalam. Angka tersebut berkisar dari 0 hingga 100, dengan angka yang lebih tinggi menunjukkan tingkat akumulasi yang lebih tinggi dibandingkan dengan perusahaan sejenis, dan 50 adalah rata-rata.
Frekuensi Pembaruan: Setiap Hari
Skor Sentimen Petugas
Skor Sentimen Pejabat menemukan perusahaan yang dibeli oleh Pejabat Korporat.
Menurut definisi, Pejabat Korporasi adalah Orang Dalam Korporasi, tetapi tidak seperti beberapa Orang Dalam lainnya (Pemegang Saham 10% dan Anggota Dewan), Pejabat bekerja untuk perusahaan setiap hari, dan mereka menggunakan uang mereka sendiri saat bertransaksi . (Pemegang Saham 10% dan Anggota Dewan seringkali adalah manajer dana yang mengelola uang orang lain.) Dengan demikian, transaksi orang dalam yang dilakukan oleh Pejabat jauh lebih signifikan dan harus ditangani dengan tepat.
Seperti Skor Sentimen Internal, Skor Sentimen Pejabat adalah hasil dari model kuantitatif multi-faktor yang canggih yang mengidentifikasi perusahaan dengan tingkat akumulasi pejabat tertinggi.
Frekuensi Pembaruan: Setiap Hari
Metrik Utama Orang Dalam
Kartu ini menunjukkan peringkat perusahaan berdasarkan berbagai metrik internal. Peringkat persentil menunjukkan bagaimana perusahaan ini dibandingkan dengan perusahaan lain di pasar AS. Peringkat yang lebih tinggi menunjukkan situasi yang lebih baik.
Sebagai contoh, secara umum diterima bahwa pembelian oleh orang dalam perusahaan adalah indikator positif, sehingga perusahaan dengan lebih banyak pembelian oleh orang dalam akan mendapat peringkat lebih tinggi daripada perusahaan dengan lebih sedikit pembelian oleh orang dalam (atau bahkan penjualan oleh orang dalam).
Jumlah Bersih Pembelian oleh Orang Dalam (Peringkat)
-6 ( )
11124 out of 11323Jumlah Bersih Pembelian oleh Orang Dalam adalah total jumlah orang dalam yang membeli dikurangi total jumlah orang dalam yang menjual dalam 90 hari terakhir. Peringkat persentil ditunjukkan di sini (kisaran dari 0 hingga 100%).
Persentase Saham yang Dibeli oleh Orang Dalam (Peringkat)
N/A
Persentase Saham yang Dibeli oleh Orang Dalam adalah total jumlah saham yang dibeli oleh orang dalam dikurangi total jumlah saham yang dijual oleh orang dalam dalam 90 hari terakhir, dibagi dengan total jumlah saham yang beredar dan dikalikan dengan 100.
Grafik Perdagangan Orang Dalam
Grafik berikut menunjukkan Bicycle Therapeutics plc - Depositary Receipt (Common Stock) transaksi orang dalam. Orang dalam adalah pejabat, direktur, atau investor signifikan dalam suatu perusahaan. Secara umum, melakukan transaksi di perusahaan mereka berdasarkan informasi material yang belum dipublikasikan adalah ilegal bagi orang dalam. Ini tidak berarti bahwa mereka dilarang melakukan transaksi apa pun di perusahaan mereka sendiri. Namun, mereka wajib melaporkan semua transaksi kepada SEC melalui Formulir 4.
Daftar Orang Dalam dan Metrik Profitabilitas
Tabel ini menampilkan daftar orang dalam yang diketahui, dan dibuat secara otomatis dari pengajuan yang diungkapkan kepada SEC. Selain nama, jabatan terbaru, dan sebutan direktur, pejabat, atau pemilik 10%, kami memberikan kepemilikan terbaru yang diungkapkan. Selain itu, jika memungkinkan, kami memberikan kinerja perdagangan historis untuk orang dalam tersebut. Kinerja perdagangan historis adalah rata-rata tertimbang dari kinerja transaksi pembelian pasar terbuka aktual yang dilakukan oleh orang dalam tersebut. Untuk informasi lebih lanjut tentang bagaimana ini dihitung, tonton webinar YouTube ini.
See our leaderboard of most profitable insider traders.
| Orang Dalam | Rata-rata Keuntungan (%) | Saham Dimiliki |
Terbagi Disesuaikan |
|---|---|---|---|
|
Aquila Investments Iv
10% Owner -
|
1,957,961 | 1,957,961 | |
| Michael Anstey Director - [D] | 1,751,437 | 1,751,437 | |
| Santiago Arroyo CHIEF DEVELOPMENT OFFICER - [O] | 69,057 | 69,057 | |
|
Baker Bros. Advisors Lp
Director, 10% Owner -
[D]
|
9,999,674 | 9,999,674 | |
| Kate Bingham Director - [D] | 38,708 | 38,708 | |
| Janice Bourque Director - [D] | 23,000 | 23,000 | |
|
Innovation Capital (Jersey) Ltd Cambridge
10% Owner -
|
1,751,437 | 1,751,437 | |
| Nigel Crockett CHIEF BUSINESS OFFICER - [O] | 51,053 | 51,053 | |
|
Plc Glaxosmithkline
10% Owner -
|
1,910,531 | 1,910,531 | |
| Jose-Carlos Gutierrez-Ramos Director - [D] | 23,000 | 23,000 | |
| Deborah Harland Director - [D] | 1,915,275 | 1,915,275 | |
| Michael Charles Ferguson Hannay CHIEF PROD & SUPPLY CHAIN OFF - [O] | 53,825 | 53,825 |
| Orang Dalam | Rata-rata Keuntungan (%) | Saham Dimiliki |
Terbagi Disesuaikan |
|---|---|---|---|
| Veronica GH Jordan Director - [D] | 16,750 | 16,750 | |
| Lee Kalowski President and CFO - [O] | 30,309 | 30,309 | |
| Nicholas Keen CHIEF SCIENTIFIC OFFICER - [O] | 62,024 | 62,024 | |
| Richard N Kender Director - [D] | 23,000 | 23,000 | |
| Kevin Lee CHIEF EXECUTIVE OFFICER, Director - [D] [O] | 480,804 | 480,804 | |
| Pierre Legault Director - [D] | 46,000 | 46,000 | |
| Peter Brian Leone | 43,269 | ||
| Alistair Milnes CHIEF OPERATING OFFICER - [O] | 95,502 | 95,502 | |
| Carolyn Ng Director - [D] | 1,427,151 | 1,427,151 | |
|
Ag Novartis
10% Owner -
|
1,769,641 | 1,769,641 | |
|
Bioventures Ltd Novartis
10% Owner -
|
1,769,641 | 1,769,641 | |
| Alessandro Riva Director - [D] | 12,500 | 12,500 | |
|
Sv Life Sciences Fund V Lp
10% Owner -
|
39,637 | 39,637 |
| Orang Dalam | Rata-rata Keuntungan (%) | Saham Dimiliki |
Terbagi Disesuaikan |
|---|---|---|---|
|
SV Life Sciences Fund V (GP), LP
10% Owner -
|
39,637 | 39,637 | |
|
SV Life Sciences Fund V Strategic Partners, L.P.
10% Owner -
|
39,637 | 39,637 | |
|
Svlsf V, Llc
10% Owner -
|
39,637 | 39,637 | |
| Sands Stephen H. Director - [D] | 17,393 | 17,393 | |
| Michael Skynner CHIEF TECHNOLOGY OFFICER - [O] | 120,079 | 120,079 | |
| Dominic Smethurst Chief Medical Officer - [O] | 36,699 | 36,699 | |
| Robert Charles Swanton Director - [D] | 3,089 | 3,089 | |
|
Capital Management Hk Ltd Tybourne
10% Owner -
|
1,957,961 | 1,957,961 | |
| Travis Alvin Thompson CHIEF ACCOUNTING OFFICER - [O] | 31,521 | 31,521 | |
|
Vertex Global Healthcare Fund I Pte Ltd.
10% Owner -
|
1,621,168 | 1,621,168 | |
| Eric Westin Chief Medical Officer - [O] | 2,305 | 2,305 | |
| Gregory Paul Winter Director - [D] | 186,927 | 186,927 | |
| Alethia Young Chief Financial Officer - [O] | 45,186 | 45,186 |
Report errors via our new Insider Auditing Tool
Rekam Jejak Pembelian Orang Dalam - Analisis Keuntungan Jangka Pendek
Pada bagian ini, kami menganalisis profitabilitas setiap pembelian saham oleh orang dalam di pasar terbuka yang tidak direncanakan yang dilakukan di BCYC / Bicycle Therapeutics plc - Depositary Receipt (Common Stock). Analisis ini membantu memahami apakah orang dalam tersebut secara konsisten menghasilkan pengembalian abnormal, dan layak untuk diikuti. Analisis ini dilakukan selama satu tahun setelah setiap transaksi, dan hasilnya bersifat teoretis .
Tabel berikut menunjukkan pembelian pasar terbuka terbaru yang bukan bagian dari rencana perdagangan otomatis.
Harga yang Disesuaikan adalah harga yang disesuaikan dengan pemisahan saham. Ang Adjusted Shares ay ang jumlah saham yang disesuaikan dengan pemisahan saham (stock split).
Rekam Jejak Penjualan Orang Dalam - Analisis Kerugian Jangka Pendek
Dalam bagian ini, kami menganalisis penghindaran kerugian jangka pendek dari setiap penjualan dalam pasar terbuka yang tidak direncanakan oleh orang dalam yang dilakukan di BCYC / Bicycle Therapeutics plc - Depositary Receipt (Common Stock). Pola penghindaran kerugian yang konsisten dapat menunjukkan bahwa transaksi penjualan di masa mendatang dapat memprediksi penurunan harga. Analisis ini berlaku untuk satu tahun setelah setiap perdagangan, dan hasilnya bersifat teoretis .
Tabel berikut menunjukkan penjualan pasar terbuka terbaru yang bukan bagian dari rencana perdagangan otomatis.
Harga yang Disesuaikan adalah harga yang disesuaikan dengan pemisahan saham. Ang Adjusted Shares ay ang jumlah saham yang disesuaikan dengan pemisahan saham (stock split).
Riwayat Transaksi
Klik ikon tautan untuk melihat riwayat transaksi lengkap. Transaksi yang dilaporkan sebagai bagian dari rencana perdagangan otomatis 10b5-1 akan memiliki tanda X di kolom yang bertanda 10b-5.
| Berkas Tanggal |
Perdagangan Tanggal |
Formulir | Orang Dalam | Ticker | Judul Keamanan | Kode | Langsung | Latihan Harga |
Satuan Harga |
Unit Diubah |
Nilai Diubah (1 ribu) |
Sisa Pilihan |
Sisa Saham |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-08-14 | 2025-08-12 | 4 | Swanton Robert Charles | BCYC | Ordinary Shares | D | 12,500 | 15,589 | ||||||
| 2025-08-14 | 3 | Swanton Robert Charles | BCYC | Ordinary Shares | D | 3,089 | ||||||||
| 2025-07-07 | 2025-07-02 | 4 | Young Alethia | BCYC | Ordinary Shares | D | 7.0900 | -204 | -1 | 45,186 | ||||
| 2025-07-07 | 2025-07-03 | 4 | Thompson Travis Alvin | BCYC | Ordinary Shares | D | 7.4400 | -100 | -1 | 31,521 | ||||
| 2025-07-07 | 2025-07-02 | 4 | Thompson Travis Alvin | BCYC | Ordinary Shares | D | 7.0900 | -206 | -1 | 31,621 | ||||
| 2025-07-07 | 2025-07-03 | 4 | Hannay Michael Charles Ferguson | BCYC | Ordinary Shares | D | 7.4400 | -248 | -2 | 53,825 | ||||
| 2025-07-07 | 2025-07-02 | 4 | Hannay Michael Charles Ferguson | BCYC | Ordinary Shares | D | 7.0900 | -474 | -3 | 54,073 | ||||
| 2025-07-07 | 2025-07-03 | 4 | Milnes Alistair | BCYC | Ordinary Shares | D | 7.4400 | -966 | -7 | 95,502 | ||||
| 2025-07-07 | 2025-07-02 | 4 | Milnes Alistair | BCYC | Ordinary Shares | D | 7.0900 | -1,149 | -8 | 96,468 | ||||
| 2025-07-07 | 2025-07-03 | 4 | Skynner Michael | BCYC | Ordinary Shares | D | 7.4400 | -966 | -7 | 120,079 | ||||
| 2025-07-07 | 2025-07-02 | 4 | Skynner Michael | BCYC | Ordinary Shares | D | 7.0900 | -825 | -6 | 121,045 | ||||
| 2025-07-07 | 2025-07-03 | 4 | Lee Kevin | BCYC | Ordinary Shares | D | 7.4400 | -3,193 | -24 | 480,804 | ||||
| 2025-07-07 | 2025-07-02 | 4 | Lee Kevin | BCYC | Ordinary Shares | D | 7.0900 | -2,268 | -16 | 483,997 | ||||
| 2025-04-04 | 2025-04-03 | 4 | Thompson Travis Alvin | BCYC | Ordinary Shares | D | 7.4800 | -109 | -1 | 31,827 | ||||
| 2025-04-04 | 2025-04-02 | 4 | Thompson Travis Alvin | BCYC | Ordinary Shares | D | 8.0200 | -210 | -2 | 31,936 | ||||
| 2025-04-04 | 2025-04-03 | 4 | Hannay Michael Charles Ferguson | BCYC | Ordinary Shares | D | 7.4800 | -266 | -2 | 54,547 | ||||
| 2025-04-04 | 2025-04-02 | 4 | Hannay Michael Charles Ferguson | BCYC | Ordinary Shares | D | 8.0200 | -467 | -4 | 54,813 | ||||
| 2025-04-04 | 2025-04-03 | 4 | Lee Kevin | BCYC | Ordinary Shares | D | 7.4800 | -3,432 | -26 | 486,265 | ||||
| 2025-04-04 | 2025-04-02 | 4 | Lee Kevin | BCYC | Ordinary Shares | D | 8.0200 | -2,237 | -18 | 489,697 | ||||
| 2025-04-04 | 2025-04-03 | 4 | Milnes Alistair | BCYC | Ordinary Shares | D | 7.4800 | -1,038 | -8 | 97,617 | ||||
| 2025-04-04 | 2025-04-02 | 4 | Milnes Alistair | BCYC | Ordinary Shares | D | 8.0200 | -1,133 | -9 | 98,655 | ||||
| 2025-04-04 | 2025-04-03 | 4 | Skynner Michael | BCYC | Ordinary Shares | D | 7.4800 | -1,038 | -8 | 121,870 | ||||
| 2025-04-04 | 2025-04-02 | 4 | Skynner Michael | BCYC | Ordinary Shares | D | 8.0200 | -814 | -7 | 122,908 | ||||
| 2025-04-04 | 2025-04-02 | 4 | Young Alethia | BCYC | Ordinary Shares | D | 8.0200 | -215 | -2 | 45,390 | ||||
| 2025-03-27 | 2025-03-25 | 4 | Riva Alessandro | BCYC | Ordinary Shares | D | 12,500 | 12,500 | ||||||
| 2025-03-27 | 3 | Westin Eric | BCYC | Ordinary Shares | D | 2,305 | ||||||||
| 2025-01-06 | 2025-01-03 | 4 | Milnes Alistair | BCYC | Ordinary Shares | D | 14.7500 | -936 | -14 | 99,788 | ||||
| 2025-01-06 | 2025-01-02 | 4 | Milnes Alistair | BCYC | Ordinary Shares | D | 14.0900 | -4,578 | -65 | 100,724 | ||||
| 2025-01-06 | 2025-01-02 | 4 | Milnes Alistair | BCYC | Ordinary Shares | D | 35,000 | 105,302 | ||||||
| 2025-01-06 | 2025-01-02 | 4 | Kender Richard N | BCYC | Ordinary Shares | D | 6,250 | 23,000 | ||||||
| 2025-01-06 | 2025-01-02 | 4 | Sands Stephen H. | BCYC | Ordinary Shares | D | 5,393 | 17,393 | ||||||
| 2025-01-06 | 2025-01-03 | 4 | Lee Kevin | BCYC | Ordinary Shares | D | 14.7500 | -3,092 | -46 | 491,934 | ||||
| 2025-01-06 | 2025-01-02 | 4 | Lee Kevin | BCYC | Ordinary Shares | D | 14.0900 | -9,038 | -127 | 495,026 | ||||
| 2025-01-06 | 2025-01-02 | 4 | Lee Kevin | BCYC | Ordinary Shares | D | 123,200 | 504,064 | ||||||
| 2025-01-06 | 2025-01-03 | 4 | Hannay Michael Charles Ferguson | BCYC | Ordinary Shares | D | 14.7500 | -239 | -4 | 55,280 | ||||
| 2025-01-06 | 2025-01-02 | 4 | Hannay Michael Charles Ferguson | BCYC | Ordinary Shares | D | 14.0900 | -1,879 | -26 | 55,519 | ||||
| 2025-01-06 | 2025-01-02 | 4 | Hannay Michael Charles Ferguson | BCYC | Ordinary Shares | D | 35,000 | 57,398 | ||||||
| 2025-01-06 | 2025-01-03 | 4 | Skynner Michael | BCYC | Ordinary Shares | D | 14.7500 | -936 | -14 | 123,722 | ||||
| 2025-01-06 | 2025-01-02 | 4 | Skynner Michael | BCYC | Ordinary Shares | D | 14.0900 | -3,287 | -46 | 124,658 | ||||
| 2025-01-06 | 2025-01-02 | 4 | Skynner Michael | BCYC | Ordinary Shares | D | 35,000 | 127,945 | ||||||
| 2025-01-06 | 2025-01-03 | 4 | Crockett Nigel | BCYC | Ordinary Shares | D | 14.7500 | -936 | -14 | 51,053 | ||||
| 2025-01-06 | 2025-01-02 | 4 | Crockett Nigel | BCYC | Ordinary Shares | D | 14.0900 | -2,583 | -36 | 51,989 | ||||
| 2025-01-06 | 2025-01-02 | 4 | Crockett Nigel | BCYC | Ordinary Shares | D | 8,750 | 54,572 | ||||||
| 2025-01-06 | 2025-01-02 | 4 | Arroyo Santiago | BCYC | Ordinary Shares | D | 14.0900 | -4,943 | -70 | 69,057 | ||||
| 2025-01-06 | 2025-01-02 | 4 | Arroyo Santiago | BCYC | Ordinary Shares | D | 35,000 | 74,000 | ||||||
| 2025-01-06 | 2025-01-02 | 4 | Young Alethia | BCYC | Ordinary Shares | D | 14.0900 | -1,395 | -20 | 45,605 | ||||
| 2025-01-06 | 2025-01-02 | 4 | Young Alethia | BCYC | Ordinary Shares | D | 35,000 | 47,000 | ||||||
| 2025-01-06 | 2025-01-06 | 4 | Thompson Travis Alvin | BCYC | Ordinary Shares | D | 15.0000 | -2,686 | -40 | 32,146 | ||||
| 2025-01-06 | 2025-01-03 | 4 | Thompson Travis Alvin | BCYC | Ordinary Shares | D | 14.7500 | -159 | -2 | 34,832 | ||||
| 2025-01-06 | 2025-01-02 | 4 | Thompson Travis Alvin | BCYC | Ordinary Shares | D | 14.0900 | -1,750 | -25 | 34,991 | ||||
| 2025-01-06 | 2025-01-02 | 4 | Thompson Travis Alvin | BCYC | Ordinary Shares | D | 17,500 | 36,741 | ||||||
| 2025-01-06 | 2025-01-02 | 4 | Legault Pierre | BCYC | Ordinary Shares | D | 12,500 | 46,000 | ||||||
| 2025-01-06 | 2025-01-02 | 4 | Bourque Janice | BCYC | Ordinary Shares | D | 6,250 | 23,000 | ||||||
| 2025-01-06 | 2025-01-02 | 4 | Winter Gregory Paul | BCYC | Ordinary Shares | D | 6,250 | 186,927 | ||||||
| 2025-01-06 | 2025-01-02 | 4 | Gutierrez-Ramos Jose-Carlos | BCYC | Ordinary Shares | D | 6,250 | 23,000 | ||||||
| 2025-01-06 | 2025-01-02 | 4 | BAKER BROS. ADVISORS LP See Footnotes | BCYC | American Depositary Shares | I | 4,400 | 9,999,674 | ||||||
| 2025-01-06 | 2025-01-02 | 4 | BAKER BROS. ADVISORS LP See Footnotes | BCYC | American Depositary Shares | I | 4,400 | 918,483 | ||||||
| 2024-12-17 | 2024-12-16 | 4 | BAKER BROS. ADVISORS LP See Footnotes | BCYC | American Depositary Shares | I | 15.3418 | 457,631 | 7,021 | 9,995,274 | ||||
| 2024-12-17 | 2024-12-16 | 4 | BAKER BROS. ADVISORS LP See Footnotes | BCYC | American Depositary Shares | I | 15.3418 | 42,369 | 650 | 914,083 | ||||
| 2024-12-17 | 2024-12-13 | 4 | BAKER BROS. ADVISORS LP See Footnotes | BCYC | American Depositary Shares | I | 13.8040 | 566,814 | 7,824 | 9,537,643 | ||||
| 2024-12-17 | 2024-12-13 | 4 | BAKER BROS. ADVISORS LP See Footnotes | BCYC | American Depositary Shares | I | 13.8040 | 52,656 | 727 | 871,714 | ||||
| 2024-12-17 | 2024-12-13 | 4 | BAKER BROS. ADVISORS LP See Footnotes | BCYC | American Depositary Shares | I | 13.7242 | 244,587 | 3,357 | 8,970,829 | ||||
| 2024-12-17 | 2024-12-13 | 4 | BAKER BROS. ADVISORS LP See Footnotes | BCYC | American Depositary Shares | I | 13.7242 | 22,722 | 312 | 819,058 | ||||
| 2024-12-17 | 2024-12-13 | 4 | BAKER BROS. ADVISORS LP See Footnotes | BCYC | American Depositary Shares | I | 13.6288 | 59,995 | 818 | 8,726,242 | ||||
| 2024-12-17 | 2024-12-13 | 4 | BAKER BROS. ADVISORS LP See Footnotes | BCYC | American Depositary Shares | I | 13.6288 | 5,573 | 76 | 796,336 | ||||
| 2024-12-17 | 2024-12-13 | 4 | BAKER BROS. ADVISORS LP See Footnotes | BCYC | American Depositary Shares | I | 13.4979 | 30,241 | 408 | 8,666,247 | ||||
| 2024-12-17 | 2024-12-13 | 4 | BAKER BROS. ADVISORS LP See Footnotes | BCYC | American Depositary Shares | I | 13.4979 | 2,809 | 38 | 790,763 | ||||
| 2024-11-13 | 2024-11-11 | 4 | Thompson Travis Alvin | BCYC | Ordinary Shares | D | 24.8200 | -231 | -6 | 19,241 | ||||
| 2024-11-13 | 2024-11-11 | 4 | Thompson Travis Alvin | BCYC | Ordinary Shares | D | 24.7700 | -209 | -5 | 19,472 | ||||
| 2024-11-13 | 2024-11-11 | 4 | Thompson Travis Alvin | BCYC | Ordinary Shares | D | 25.2100 | -3,241 | -82 | 19,681 | ||||
| 2024-11-13 | 2024-11-11 | 4 | Thompson Travis Alvin | BCYC | Ordinary Shares | D | 25.0500 | -1,109 | -28 | 22,922 | ||||
| 2024-11-13 | 2024-11-11 | 4 | Thompson Travis Alvin | BCYC | Ordinary Shares | D | 9.8200 | 1,109 | 11 | 24,031 | ||||
| 2024-11-13 | 2024-11-11 | 4 | Thompson Travis Alvin | BCYC | Ordinary Shares | D | 25.0100 | -154 | -4 | 22,922 | ||||
| 2024-11-13 | 2024-11-11 | 4 | Thompson Travis Alvin | BCYC | Ordinary Shares | D | 8.2100 | 154 | 1 | 23,076 | ||||
| 2024-11-13 | 2024-11-11 | 4 | Thompson Travis Alvin | BCYC | Ordinary Shares | D | 25.0500 | -1,312 | -33 | 22,922 | ||||
| 2024-11-13 | 2024-11-11 | 4 | Thompson Travis Alvin | BCYC | Ordinary Shares | D | 1.8700 | 1,312 | 2 | 24,234 | ||||
| 2024-10-04 | 2024-10-03 | 4 | Milnes Alistair | BCYC | Ordinary Shares | D | 22.2600 | -972 | -22 | 70,302 | ||||
| 2024-10-04 | 2024-10-03 | 4 | Skynner Michael | BCYC | Ordinary Shares | D | 22.2600 | -972 | -22 | 92,945 | ||||
| 2024-10-04 | 2024-10-03 | 4 | Hannay Michael Charles Ferguson | BCYC | Ordinary Shares | D | 22.2600 | -247 | -5 | 22,398 | ||||
| 2024-10-04 | 2024-10-03 | 4 | Lee Kevin | BCYC | Ordinary Shares | D | 22.2600 | -3,212 | -71 | 380,864 | ||||
| 2024-10-04 | 2024-10-03 | 4 | Thompson Travis Alvin | BCYC | Ordinary Shares | D | 22.2600 | -153 | -3 | 22,922 | ||||
| 2024-10-04 | 2024-10-03 | 4 | Crockett Nigel | BCYC | Ordinary Shares | D | 22.2600 | -972 | -22 | 45,822 | ||||
| 2024-07-08 | 2024-07-03 | 4 | Hannay Michael Charles Ferguson | BCYC | Ordinary Shares | D | 19.6400 | -246 | -5 | 22,645 | ||||
| 2024-07-08 | 2024-07-03 | 4 | Milnes Alistair | BCYC | Ordinary Shares | D | 19.6400 | -967 | -19 | 71,274 | ||||
| 2024-07-08 | 2024-07-03 | 4 | Lee Kevin | BCYC | Ordinary Shares | D | 19.6400 | -3,194 | -63 | 384,076 | ||||
| 2024-07-08 | 2024-07-03 | 4 | Crockett Nigel | BCYC | Ordinary Shares | D | 19.6400 | -967 | -19 | 46,794 | ||||
| 2024-07-08 | 2024-07-03 | 4 | Keen Nicholas | BCYC | Ordinary Shares | D | 19.6400 | -779 | -15 | 62,024 | ||||
| 2024-07-08 | 2024-07-03 | 4 | Thompson Travis Alvin | BCYC | Ordinary Shares | D | 19.6400 | -148 | -3 | 23,075 | ||||
| 2024-07-08 | 2024-07-03 | 4 | Skynner Michael | BCYC | Ordinary Shares | D | 19.6400 | -967 | -19 | 93,917 | ||||
| 2024-06-20 | 2024-06-17 | 4 | BAKER BROS. ADVISORS LP See Footnotes | BCYC | American Depositary Shares | I | 2,186,686 | 8,636,006 | ||||||
| 2024-06-20 | 2024-06-17 | 4 | BAKER BROS. ADVISORS LP See Footnotes | BCYC | American Depositary Shares | I | 196,098 | 787,954 | ||||||
| 2024-04-22 | 2024-04-18 | 4 | BAKER BROS. ADVISORS LP See Footnotes | BCYC | American Depositary Shares | I | 12,000 | 6,449,320 | ||||||
| 2024-04-22 | 2024-04-18 | 4 | BAKER BROS. ADVISORS LP See Footnotes | BCYC | American Depositary Shares | I | 12,000 | 6,449,320 | ||||||
| 2024-04-18 | 3 | BAKER BROS. ADVISORS LP See Footnotes | BCYC | American Depositary Shares | I | 6,437,320 | ||||||||
| 2024-04-18 | 3 | BAKER BROS. ADVISORS LP See Footnotes | BCYC | American Depositary Shares | I | 579,856 | ||||||||
| 2024-04-12 | 2024-04-11 | 4 | Hannay Michael Charles Ferguson | BCYC | Ordinary Shares | D | 22.4900 | -257 | -6 | 22,891 | ||||
| 2024-04-05 | 2024-04-03 | 4 | Thompson Travis Alvin | BCYC | Ordinary Shares | D | 23.8100 | -152 | -4 | 23,223 | ||||
| 2024-04-05 | 2024-04-03 | 4 | Keen Nicholas | BCYC | Ordinary Shares | D | 23.8100 | -790 | -19 | 62,803 | ||||
| 2024-04-05 | 2024-04-03 | 4 | Crockett Nigel | BCYC | Ordinary Shares | D | 23.8100 | -955 | -23 | 47,761 | ||||
| 2024-04-05 | 2024-04-03 | 4 | Milnes Alistair | BCYC | Ordinary Shares | D | 23.8100 | -955 | -23 | 72,241 | ||||
| 2024-04-05 | 2024-04-03 | 4 | Skynner Michael | BCYC | Ordinary Shares | D | 23.8100 | -955 | -23 | 94,884 | ||||
| 2024-04-05 | 2024-04-03 | 4 | Lee Kevin | BCYC | Ordinary Shares | D | 23.8100 | -3,158 | -75 | 387,270 | ||||
| 2024-03-21 | 3 | Hannay Michael Charles Ferguson | BCYC | Ordinary Shares | D | 23,148 | ||||||||
| 2024-02-21 | 2024-02-20 | 4 | Sands Stephen H. | BCYC | Ordinary Shares | D | 12,000 | 12,000 | ||||||
| 2024-02-08 | 2024-02-06 | 4 | Arroyo Santiago | BCYC | Ordinary Shares | D | 21,660 | 39,000 | ||||||
| 2024-01-04 | 2024-01-03 | 4 | Thompson Travis Alvin | BCYC | Ordinary Shares | D | 17.5000 | -604 | -11 | 23,375 | ||||
| 2024-01-04 | 2024-01-02 | 4 | Thompson Travis Alvin | BCYC | Ordinary Shares | D | 16,000 | 23,979 | ||||||
| 2024-01-04 | 2024-01-02 | 4 | Legault Pierre | BCYC | Ordinary Shares | D | 12,000 | 33,500 | ||||||
| 2024-01-04 | 2024-01-03 | 4 | Keen Nicholas | BCYC | Ordinary Shares | D | 17.5000 | -2,640 | -46 | 63,593 | ||||
| 2024-01-04 | 2024-01-02 | 4 | Keen Nicholas | BCYC | Ordinary Shares | D | 28,000 | 66,233 | ||||||
| 2024-01-04 | 2024-01-02 | 4 | Bourque Janice | BCYC | Ordinary Shares | D | 6,000 | 16,750 | ||||||
| 2024-01-04 | 2024-01-02 | 4 | Gutierrez-Ramos Jose-Carlos | BCYC | Ordinary Shares | D | 6,000 | 16,750 | ||||||
| 2024-01-04 | 2024-01-02 | 4 | Winter Gregory Paul | BCYC | Ordinary Shares | D | 6,000 | 180,677 | ||||||
| 2024-01-04 | 2024-01-02 | 4 | Jordan Veronica GH | BCYC | Ordinary Shares | D | 6,000 | 16,750 | ||||||
| 2024-01-04 | 2024-01-02 | 4 | Kender Richard N | BCYC | Ordinary Shares | D | 6,000 | 16,750 | ||||||
| 2024-01-04 | 2024-01-02 | 4 | Arroyo Santiago | BCYC | Ordinary Shares | D | 17,340 | 17,340 | ||||||
| 2024-01-04 | 2024-01-03 | 4 | Crockett Nigel | BCYC | Ordinary Shares | D | 17.5000 | -2,643 | -46 | 48,716 | ||||
| 2024-01-04 | 2024-01-02 | 4 | Crockett Nigel | BCYC | Ordinary Shares | D | 22,000 | 51,359 | ||||||
| 2024-01-04 | 2024-01-03 | 4 | Milnes Alistair | BCYC | Ordinary Shares | D | 17.5000 | -2,643 | -46 | 73,196 | ||||
| 2024-01-04 | 2024-01-02 | 4 | Milnes Alistair | BCYC | Ordinary Shares | D | 39,000 | 75,839 | ||||||
| 2024-01-04 | 2024-01-02 | 4 | Young Alethia | BCYC | Ordinary Shares | D | 12,000 | 12,000 | ||||||
| 2024-01-04 | 2024-01-03 | 4 | Lee Kevin | BCYC | Ordinary Shares | D | 17.5000 | -8,703 | -152 | 390,428 | ||||
| 2024-01-04 | 2024-01-02 | 4 | Lee Kevin | BCYC | Ordinary Shares | D | 77,000 | 399,131 | ||||||
| 2024-01-04 | 2024-01-03 | 4 | Skynner Michael | BCYC | Ordinary Shares | D | 17.5000 | -2,643 | -46 | 95,839 | ||||
| 2024-01-04 | 2024-01-02 | 4 | Skynner Michael | BCYC | Ordinary Shares | D | 28,000 | 98,482 | ||||||
| 2023-10-05 | 2023-10-03 | 4 | Thompson Travis Alvin | BCYC | Ordinary Shares | D | 20.0000 | -54 | -1 | 7,979 | ||||
| 2023-10-05 | 2023-10-03 | 4 | Keen Nicholas | BCYC | Ordinary Shares | D | 20.0000 | -272 | -5 | 38,233 | ||||
| 2023-10-05 | 2023-10-03 | 4 | Crockett Nigel | BCYC | Ordinary Shares | D | 20.0000 | -442 | -9 | 29,359 | ||||
| 2023-10-05 | 2023-10-03 | 4 | Lee Kevin | BCYC | Ordinary Shares | D | 20.0000 | -1,470 | -29 | 322,131 | ||||
| 2023-10-05 | 2023-10-03 | 4 | Milnes Alistair | BCYC | Ordinary Shares | D | 20.0000 | -442 | -9 | 36,839 | ||||
| 2023-10-05 | 2023-10-03 | 4 | Skynner Michael | BCYC | Ordinary Shares | D | 20.0000 | -442 | -9 | 70,482 | ||||
| 2023-07-06 | 2023-07-03 | 4 | Crockett Nigel | BCYC | Ordinary Shares | D | 25.1000 | -451 | -11 | 29,801 | ||||
| 2023-07-06 | 2023-07-03 | 4 | Lee Kevin | BCYC | Ordinary Shares | D | 25.1000 | -1,498 | -38 | 323,601 | ||||
| 2023-07-06 | 2023-07-03 | 4 | Milnes Alistair | BCYC | Ordinary Shares | D | 25.1000 | -451 | -11 | 37,281 | ||||
| 2023-07-06 | 2023-07-03 | 4 | Thompson Travis Alvin | BCYC | Ordinary Shares | D | 25.1000 | -61 | -2 | 8,033 | ||||
| 2023-07-06 | 2023-07-03 | 4 | Keen Nicholas | BCYC | Ordinary Shares | D | 25.1000 | -336 | -8 | 38,505 | ||||
| 2023-07-06 | 2023-07-03 | 4 | Skynner Michael | BCYC | Ordinary Shares | D | 25.1000 | -451 | -11 | 70,924 | ||||
| 2023-07-03 | 3 | Thompson Travis Alvin | BCYC | Ordinary Shares | D | 8,094 | ||||||||
| 2023-04-05 | 2023-04-03 | 4 | Skynner Michael | BCYC | Ordinary Shares | D | 21.1100 | -447 | -9 | 71,375 | ||||
| 2023-04-05 | 2023-04-03 | 4 | Keen Nicholas | BCYC | Ordinary Shares | D | 21.1100 | -319 | -7 | 38,841 | ||||
| 2023-04-05 | 2023-04-03 | 4 | Milnes Alistair | BCYC | Ordinary Shares | D | 21.1100 | -447 | -9 | 37,732 | ||||
| 2023-04-05 | 2023-04-03 | 4 | Kalowski Lee | BCYC | Ordinary Shares | D | 21.1100 | -376 | -8 | 30,309 | ||||
| 2023-04-05 | 2023-04-03 | 4 | Lee Kevin | BCYC | Ordinary Shares | D | 21.1100 | -1,486 | -31 | 325,099 | ||||
| 2023-04-05 | 2023-04-03 | 4 | Crockett Nigel | BCYC | Ordinary Shares | D | 21.1100 | -447 | -9 | 30,252 | ||||
| 2023-01-05 | 2023-01-03 | 4 | Gutierrez-Ramos Jose-Carlos | BCYC | Ordinary Shares | D | 5,750 | 10,750 | ||||||
| 2023-01-05 | 2023-01-03 | 4 | Jordan Veronica GH | BCYC | Ordinary Shares | D | 5,750 | 10,750 | ||||||
| 2023-01-05 | 2023-01-03 | 4 | Skynner Michael | BCYC | Ordinary Shares | D | 29.0600 | -1,801 | -52 | 71,822 | ||||
| 2023-01-05 | 2023-01-03 | 4 | Skynner Michael | BCYC | Ordinary Shares | D | 17,500 | 73,623 | ||||||
| 2023-01-05 | 2023-01-03 | 4 | Lee Kevin | BCYC | Ordinary Shares | D | 29.0600 | -6,000 | -174 | 326,585 | ||||
| 2023-01-05 | 2023-01-03 | 4 | Lee Kevin | BCYC | Ordinary Shares | D | 57,500 | 332,585 | ||||||
| 2023-01-05 | 2023-01-03 | 4 | Winter Gregory Paul | BCYC | Ordinary Shares | D | 5,750 | 174,677 | ||||||
| 2023-01-05 | 2023-01-03 | 4 | Legault Pierre | BCYC | Ordinary Shares | D | 11,500 | 21,500 | ||||||
| 2023-01-05 | 2023-01-03 | 4 | Kalowski Lee | BCYC | Ordinary Shares | D | 29.0600 | -1,815 | -53 | 30,685 | ||||
| 2023-01-05 | 2023-01-03 | 4 | Kalowski Lee | BCYC | Ordinary Shares | D | 17,500 | 32,500 | ||||||
| 2023-01-05 | 2023-01-03 | 4 | Kender Richard N | BCYC | Ordinary Shares | D | 5,750 | 10,750 | ||||||
| 2023-01-05 | 2023-01-03 | 4 | Keen Nicholas | BCYC | Ordinary Shares | D | 29.0600 | -1,817 | -53 | 39,160 | ||||
| 2023-01-05 | 2023-01-03 | 4 | Keen Nicholas | BCYC | Ordinary Shares | D | 17,500 | 40,977 | ||||||
| 2023-01-05 | 2023-01-03 | 4 | Crockett Nigel | BCYC | Ordinary Shares | D | 29.0600 | -1,801 | -52 | 30,699 | ||||
| 2023-01-05 | 2023-01-03 | 4 | Crockett Nigel | BCYC | Ordinary Shares | D | 17,500 | 32,500 | ||||||
| 2023-01-05 | 2023-01-03 | 4 | Bourque Janice | BCYC | Ordinary Shares | D | 5,750 | 10,750 | ||||||
| 2023-01-05 | 2023-01-03 | 4 | Smethurst Dominic | BCYC | Ordinary Shares | D | 29.0600 | -1,801 | -52 | 36,699 | ||||
| 2023-01-05 | 2023-01-03 | 4 | Smethurst Dominic | BCYC | Ordinary Shares | D | 17,500 | 38,500 | ||||||
| 2023-01-05 | 2023-01-03 | 4 | Milnes Alistair | BCYC | Ordinary Shares | D | 29.0600 | -1,801 | -52 | 38,179 | ||||
| 2023-01-05 | 2023-01-03 | 4 | Milnes Alistair | BCYC | Ordinary Shares | D | 17,500 | 39,980 | ||||||
| 2022-03-29 | 2022-03-25 | 4 | Milnes Alistair | BCYC | Employee Stock Option (right to buy) | D | 20.12 | 5,155 | 46,845 | |||||
| 2022-03-29 | 2022-03-25 | 4 | Milnes Alistair | BCYC | Ordinary Shares | D | 20.1200 | 5,155 | 104 | 22,480 | ||||
| 2022-03-29 | 3/A | Milnes Alistair | BCYC | Ordinary Shares | D | 2,325 | ||||||||
| 2022-01-05 | 2022-01-03 | 4 | Jordan Veronica GH | BCYC | Stock Option (right to buy) | D | 60.87 | 10,000 | 10,000 | |||||
| 2022-01-05 | 2022-01-03 | 4 | Jordan Veronica GH | BCYC | Ordinary Shares | D | 5,000 | 5,000 | ||||||
| 2022-01-05 | 2022-01-03 | 4 | Winter Gregory Paul | BCYC | Stock Option (right to buy) | D | 60.87 | 10,000 | 10,000 | |||||
| 2022-01-05 | 2022-01-03 | 4 | Winter Gregory Paul | BCYC | Ordinary Shares | D | 5,000 | 168,927 | ||||||
| 2022-01-05 | 2022-01-03 | 4 | Skynner Michael | BCYC | Employee Stock Option (right to buy) | D | 60.87 | 30,000 | 30,000 | |||||
| 2022-01-05 | 2022-01-03 | 4 | Skynner Michael | BCYC | Ordinary Shares | D | 15,000 | 56,123 | ||||||
| 2022-01-05 | 2022-01-03 | 4 | Smethurst Dominic | BCYC | Employee Stock Option (right to buy) | D | 60.87 | 30,000 | 30,000 | |||||
| 2022-01-05 | 2022-01-03 | 4 | Smethurst Dominic | BCYC | Ordinary Shares | D | 15,000 | 21,000 | ||||||
| 2022-01-05 | 2022-01-03 | 4 | Lee Kevin | BCYC | Employee Stock Option (right to buy) | D | 60.87 | 100,000 | 100,000 | |||||
| 2022-01-05 | 2022-01-03 | 4 | Lee Kevin | BCYC | Ordinary Shares | D | 50,000 | 275,085 | ||||||
| 2022-01-05 | 2022-01-03 | 4 | Legault Pierre | BCYC | Stock Option (right to buy) | D | 60.87 | 20,000 | 20,000 | |||||
| 2022-01-05 | 2022-01-03 | 4 | Legault Pierre | BCYC | Ordinary Shares | D | 10,000 | 10,000 | ||||||
| 2022-01-05 | 2022-01-03 | 4 | Kender Richard N | BCYC | Stock Option (right to buy) | D | 60.87 | 10,000 | 10,000 | |||||
| 2022-01-05 | 2022-01-03 | 4 | Kender Richard N | BCYC | Ordinary Shares | D | 5,000 | 5,000 | ||||||
| 2022-01-05 | 2022-01-03 | 4 | Kalowski Lee | BCYC | Employee Stock Option (right to buy) | D | 60.87 | 30,000 | 30,000 | |||||
| 2022-01-05 | 2022-01-03 | 4 | Kalowski Lee | BCYC | Ordinary Shares | D | 15,000 | 15,000 | ||||||
| 2022-01-05 | 2022-01-03 | 4 | Keen Nicholas | BCYC | Employee Stock Option (right to buy) | D | 60.87 | 30,000 | 30,000 | |||||
| 2022-01-05 | 2022-01-03 | 4 | Keen Nicholas | BCYC | Ordinary Shares | D | 15,000 | 23,477 | ||||||
| 2022-01-05 | 2022-01-03 | 4 | Gutierrez-Ramos Jose-Carlos | BCYC | Stock Option (right to buy) | D | 60.87 | 10,000 | 10,000 | |||||
| 2022-01-05 | 2022-01-03 | 4 | Gutierrez-Ramos Jose-Carlos | BCYC | Ordinary Shares | D | 5,000 | 5,000 | ||||||
| 2022-01-05 | 2022-01-03 | 4 | Crockett Nigel | BCYC | Employee Stock Option (right to buy) | D | 60.87 | 30,000 | 30,000 | |||||
| 2022-01-05 | 2022-01-03 | 4 | Crockett Nigel | BCYC | Ordinary Shares | D | 15,000 | 15,000 | ||||||
| 2022-01-05 | 2022-01-03 | 4 | Bourque Janice | BCYC | Stock Option (right to buy) | D | 60.87 | 10,000 | 10,000 | |||||
| 2022-01-05 | 2022-01-03 | 4 | Bourque Janice | BCYC | Ordinary Shares | D | 5,000 | 5,000 | ||||||
| 2022-01-05 | 2022-01-03 | 4 | Milnes Alistair | BCYC | Employee Stock Option (right to buy) | D | 60.87 | 100,000 | 100,000 | |||||
| 2022-01-05 | 2022-01-03 | 4 | Milnes Alistair | BCYC | Ordinary Shares | D | 15,000 | 15,000 | ||||||
| 2021-12-22 | 2021-12-21 | 4 | Keen Nicholas | BCYC | Stock Option (Right to Buy) | D | 14.00 | -15,477 | 161,927 | |||||
| 2021-12-22 | 2021-12-21 | 4 | Keen Nicholas | BCYC | Ordinary Shares | D | 14.0000 | 15,477 | 217 | 15,477 | ||||
| 2021-12-22 | 2021-12-22 | 4 | Legault Pierre | BCYC | Stock Option (Right to Buy) | D | 8.48 | -97,860 | 23,312 | |||||
| 2021-12-22 | 2021-12-22 | 4 | Legault Pierre | BCYC | Ordinary Shares | D | 58.0100 | -97,860 | -5,677 | 0 | ||||
| 2021-12-22 | 2021-12-22 | 4 | Legault Pierre | BCYC | Ordinary Shares | D | 8.4800 | 97,860 | 830 | 97,860 | ||||
| 2021-12-22 | 2021-12-21 | 4 | Legault Pierre | BCYC | Stock Option (Right to Buy) | D | 8.44 | -44,537 | 121,172 | |||||
| 2021-12-22 | 2021-12-21 | 4 | Legault Pierre | BCYC | Ordinary Shares | D | 57.1100 | -44,537 | -2,544 | 0 | ||||
| 2021-12-22 | 2021-12-21 | 4 | Legault Pierre | BCYC | Ordinary Shares | D | 8.4400 | 44,537 | 376 | 44,537 | ||||
| 2021-12-22 | 2021-12-20 | 4 | Legault Pierre | BCYC | Stock Option (Right to Buy) | D | 8.41 | -7,603 | 165,709 | |||||
| 2021-12-22 | 2021-12-20 | 4 | Legault Pierre | BCYC | Ordinary Shares | D | 57.0200 | -7,603 | -434 | 0 | ||||
| 2021-12-22 | 2021-12-20 | 4 | Legault Pierre | BCYC | Ordinary Shares | D | 8.4100 | 7,603 | 64 | 7,603 | ||||
| 2021-10-18 | 2021-10-18 | 4 | Lee Kevin | BCYC | Ordinary Shares | D | 60.0000 | -49 | -3 | 225,085 | ||||
| 2021-10-18 | 2021-10-15 | 4 | Lee Kevin | BCYC | Ordinary Shares | D | 60.0500 | -320 | -19 | 225,134 | ||||
| 2021-10-18 | 2021-10-14 | 4 | Lee Kevin | BCYC | Ordinary Shares | D | 60.0000 | -4,631 | -278 | 225,454 | ||||
| 2021-10-13 | 2021-10-11 | 4 | Lee Kevin | BCYC | Ordinary Shares | D | 54.6700 | -598 | -33 | 230,085 | ||||
| 2021-10-13 | 2021-10-11 | 4 | Lee Kevin | BCYC | Ordinary Shares | D | 53.7700 | -4,402 | -237 | 230,683 | ||||
| 2021-10-05 | 2021-10-05 | 4 | Keen Nicholas | BCYC | Ordinary Shares | D | 45.1000 | -2,178 | -98 | 0 | ||||
| 2021-10-05 | 2021-10-01 | 4 | Keen Nicholas | BCYC | Ordinary Shares | D | 45.0000 | -1,188 | -53 | 2,178 | ||||
| 2021-09-27 | 2021-09-23 | 4 | Smethurst Dominic | BCYC | Employee Stock Option (right to buy) | D | 18.55 | -6,000 | 114,000 | |||||
| 2021-09-27 | 2021-09-23 | 4 | Smethurst Dominic | BCYC | Ordinary Shares | D | 18.5500 | 6,000 | 111 | 6,000 | ||||
| 2021-09-17 | 2021-09-16 | 4 | Keen Nicholas | BCYC | Ordinary Shares | D | 45.0100 | -1,955 | -88 | 3,366 | ||||
| 2021-09-17 | 2021-09-15 | 4 | Keen Nicholas | BCYC | Ordinary Shares | D | 45.0000 | -3,000 | -135 | 5,321 | ||||
| 2021-09-03 | 2021-09-02 | 4 | Kalowski Lee | BCYC | Employee Stock Option (right to buy) | D | 9.82 | -10,000 | 50,000 | |||||
| 2021-09-03 | 2021-09-02 | 4 | Kalowski Lee | BCYC | Ordinary Shares | D | 40.0000 | -10,000 | -400 | 0 | ||||
| 2021-09-03 | 2021-09-02 | 4 | Kalowski Lee | BCYC | Ordinary Shares | D | 9.8200 | 10,000 | 98 | 10,000 | ||||
| 2021-09-03 | 2021-09-02 | 4 | Keen Nicholas | BCYC | Ordinary Shares | D | 40.0000 | -10,000 | -400 | 8,321 | ||||
| 2021-09-03 | 2021-09-02 | 4 | Lee Kevin | BCYC | Ordinary Shares | D | 40.0000 | -5,000 | -200 | 235,085 | ||||
| 2021-09-03 | 2021-09-01 | 4 | Lee Kevin | BCYC | Stock Option (right to buy) | D | 14.00 | -22,890 | 306,252 | |||||
| 2021-09-03 | 2021-09-01 | 4 | Lee Kevin | BCYC | Ordinary Shares | D | 38.0800 | -1,796 | -68 | 240,085 | ||||
| 2021-09-03 | 2021-09-01 | 4 | Lee Kevin | BCYC | Ordinary Shares | D | 37.5200 | -17,098 | -642 | 241,881 | ||||
| 2021-09-03 | 2021-09-01 | 4 | Lee Kevin | BCYC | Ordinary Shares | D | 36.3800 | -8,191 | -298 | 258,979 | ||||
| 2021-09-03 | 2021-09-01 | 4 | Lee Kevin | BCYC | Ordinary Shares | D | 14.0000 | 22,890 | 320 | 267,170 | ||||
| 2021-08-31 | 2021-08-31 | 4 | Lee Kevin | BCYC | Stock Option (right to buy) | D | 14.00 | -10,420 | 329,142 | |||||
| 2021-08-31 | 2021-08-31 | 4 | Lee Kevin | BCYC | Ordinary Shares | D | 37.0800 | -1,272 | -47 | 244,280 | ||||
| 2021-08-31 | 2021-08-31 | 4 | Lee Kevin | BCYC | Ordinary Shares | D | 36.2300 | -9,953 | -361 | 245,552 | ||||
| 2021-08-31 | 2021-08-31 | 4 | Lee Kevin | BCYC | Ordinary Shares | D | 14.0000 | 10,420 | 146 | 255,505 | ||||
| 2021-08-31 | 2021-08-27 | 4 | Lee Kevin | BCYC | Stock Option (right to buy) | D | 14.00 | -1,808 | 339,562 | |||||
| 2021-08-31 | 2021-08-27 | 4 | Lee Kevin | BCYC | Ordinary Shares | D | 36.0200 | -1,808 | -65 | 245,085 | ||||
| 2021-08-31 | 2021-08-27 | 4 | Lee Kevin | BCYC | Ordinary Shares | D | 14.0000 | 1,808 | 25 | 246,893 | ||||
| 2021-08-27 | 2021-08-27 | 4 | Kalowski Lee | BCYC | Stock Option (Right to Buy) | D | 8.73 | -7,950 | 5,768 | |||||
| 2021-08-27 | 2021-08-27 | 4 | Kalowski Lee | BCYC | Ordinary Shares | D | 35.1500 | -7,950 | -279 | 0 | ||||
| 2021-08-27 | 2021-08-27 | 4 | Kalowski Lee | BCYC | Ordinary Shares | D | 8.7300 | 7,950 | 69 | 7,950 | ||||
| 2021-08-27 | 2021-08-26 | 4 | Kalowski Lee | BCYC | Stock Option (Right to Buy) | D | 8.76 | -550 | 13,718 | |||||
| 2021-08-27 | 2021-08-26 | 4 | Kalowski Lee | BCYC | Ordinary Shares | D | 35.0400 | -550 | -19 | 0 | ||||
| 2021-08-27 | 2021-08-26 | 4 | Kalowski Lee | BCYC | Ordinary Shares | D | 8.7600 | 550 | 5 | 550 | ||||
| 2021-08-25 | 2021-08-23 | 4 | Kalowski Lee | BCYC | Stock Option (Right to Buy) | D | 1.60 | -7,500 | 59,774 | |||||
| 2021-08-25 | 2021-08-23 | 4 | Kalowski Lee | BCYC | Ordinary Shares | D | 33.0200 | -7,500 | -248 | 0 | ||||
| 2021-08-25 | 2021-08-23 | 4 | Kalowski Lee | BCYC | Ordinary Shares | D | 1.6000 | 7,500 | 12 | 7,500 | ||||
| 2021-07-30 | 2021-07-29 | 4 | Kalowski Lee | BCYC | Stock Option (Right to Buy) | D | 1.63 | -12,500 | 67,274 | |||||
| 2021-07-30 | 2021-07-29 | 4 | Kalowski Lee | BCYC | Ordinary Shares | D | 32.8100 | -300 | -10 | 0 | ||||
| 2021-07-30 | 2021-07-29 | 4 | Kalowski Lee | BCYC | Ordinary Shares | D | 32.1300 | -3,204 | -103 | 300 | ||||
| 2021-07-30 | 2021-07-29 | 4 | Kalowski Lee | BCYC | Ordinary Shares | D | 31.2400 | -8,996 | -281 | 3,504 | ||||
| 2021-07-30 | 2021-07-29 | 4 | Kalowski Lee | BCYC | Ordinary Shares | D | 1.6300 | 12,500 | 20 | 12,500 | ||||
| 2021-07-27 | 2021-07-26 | 4 | Lee Kevin | BCYC | Stock Option (right to buy) | D | 14.00 | -100 | 341,370 | |||||
| 2021-07-27 | 2021-07-26 | 4 | Lee Kevin | BCYC | Ordinary Shares | D | 36.0000 | -100 | -4 | 245,085 | ||||
| 2021-07-27 | 2021-07-26 | 4 | Lee Kevin | BCYC | Ordinary Shares | D | 14.0000 | 100 | 1 | 245,185 | ||||
| 2021-07-27 | 2021-07-23 | 4 | Lee Kevin | BCYC | Stock Option (right to buy) | D | 14.00 | -4,782 | 341,470 | |||||
| 2021-07-27 | 2021-07-23 | 4 | Lee Kevin | BCYC | Ordinary Shares | D | 36.0200 | -4,782 | -172 | 245,085 | ||||
| 2021-07-27 | 2021-07-23 | 4 | Lee Kevin | BCYC | Ordinary Shares | D | 14.0000 | 4,782 | 67 | 249,867 | ||||
| 2021-07-20 | 2021-07-14 | 4/A | BINGHAM KATE By SV Life Sciences Fund V Strategic Partners, L.P. | BCYC | Ordinary Shares | I | 34.0076 | -917 | -31 | 38,708 | ||||
| 2021-07-20 | 2021-07-14 | 4/A | BINGHAM KATE By SV Life Sciences Fund V, L.P. | BCYC | Ordinary Shares | I | 34.0076 | -43,378 | -1,475 | 1,831,671 | ||||
| 2021-07-20 | 2021-07-13 | 4/A | BINGHAM KATE By SV Life Sciences Fund V Strategic Partners, L.P. | BCYC | Ordinary Shares | I | 33.5000 | -12 | -0 | 39,625 | ||||
| 2021-07-20 | 2021-07-13 | 4/A | BINGHAM KATE By SV Life Sciences Fund V, L.P. | BCYC | Ordinary Shares | I | 33.5000 | -588 | -20 | 1,875,049 | ||||
| 2021-07-16 | 2021-07-14 | 4 | Keen Nicholas | BCYC | Ordinary Shares | D | 35.0000 | -10,000 | -350 | 18,321 | ||||
| 2021-07-16 | 2021-07-16 | 4 | Lee Kevin | BCYC | Stock Option (right to buy) | D | 14.00 | -609 | 346,252 | |||||
| 2021-07-16 | 2021-07-16 | 4 | Lee Kevin | BCYC | Ordinary Shares | D | 34.0000 | -609 | -21 | 245,085 | ||||
| 2021-07-16 | 2021-07-16 | 4 | Lee Kevin | BCYC | Ordinary Shares | D | 14.0000 | 609 | 9 | 245,694 | ||||
| 2021-07-16 | 2021-07-15 | 4 | Lee Kevin | BCYC | Stock Option (right to buy) | D | 14.00 | -21,970 | 346,861 | |||||
| 2021-07-16 | 2021-07-15 | 4 | Lee Kevin | BCYC | Ordinary Shares | D | 34.2800 | -21,970 | -753 | 245,085 | ||||
| 2021-07-16 | 2021-07-15 | 4 | Lee Kevin | BCYC | Ordinary Shares | D | 14.0000 | 21,970 | 308 | 267,055 | ||||
| 2021-07-15 | 2021-07-14 | 4 | BINGHAM KATE By SV Life Sciences Fund V Strategic Partners, L.P. | BCYC | Ordinary Shares | I | 34.0076 | -917 | -31 | 38,708 | ||||
| 2021-07-15 | 2021-07-14 | 4 | BINGHAM KATE By SV Life Sciences Fund V, L.P. | BCYC | Ordinary Shares | I | 34.0076 | -43,378 | -1,475 | 1,831,671 | ||||
| 2021-07-15 | 2021-07-13 | 4 | BINGHAM KATE By SV Life Sciences Fund V Strategic Partners, L.P. | BCYC | Ordinary Shares | I | 33.5000 | -12 | -0 | 39,625 | ||||
| 2021-07-15 | 2021-07-13 | 4 | BINGHAM KATE By SV Life Sciences Fund V, L.P. | BCYC | Ordinary Shares | I | 33.5000 | -588 | -20 | 1,875,049 | ||||
| 2021-07-14 | 2021-07-14 | 4 | Lee Kevin | BCYC | Stock Option (right to buy) | D | 14.00 | -8,331 | 368,831 | |||||
| 2021-07-14 | 2021-07-14 | 4 | Lee Kevin | BCYC | Ordinary Shares | D | 35.1600 | -53 | -2 | 245,085 | ||||
| 2021-07-14 | 2021-07-14 | 4 | Lee Kevin | BCYC | Ordinary Shares | D | 34.8900 | -9,084 | -317 | 245,138 | ||||
| 2021-07-14 | 2021-07-14 | 4 | Lee Kevin | BCYC | Ordinary Shares | D | 33.8500 | -2,686 | -91 | 254,222 | ||||
| 2021-07-14 | 2021-07-14 | 4 | Lee Kevin | BCYC | Ordinary Shares | D | 32.9300 | -2,642 | -87 | 256,908 | ||||
| 2021-07-14 | 2021-07-14 | 4 | Lee Kevin | BCYC | Ordinary Shares | D | 14.0000 | 8,331 | 117 | 259,550 | ||||
| 2021-07-14 | 2021-07-13 | 4 | Lee Kevin | BCYC | Stock Option (right to buy) | D | 14.00 | -35,446 | 377,162 | |||||
| 2021-07-14 | 2021-07-13 | 4 | Lee Kevin | BCYC | Ordinary Shares | D | 34.0000 | -11,194 | -381 | 251,219 | ||||
| 2021-07-14 | 2021-07-13 | 4 | Lee Kevin | BCYC | Ordinary Shares | D | 33.0900 | -5,788 | -192 | 262,413 | ||||
| 2021-07-14 | 2021-07-13 | 4 | Lee Kevin | BCYC | Ordinary Shares | D | 32.4200 | -21,979 | -713 | 268,201 | ||||
| 2021-07-14 | 2021-07-13 | 4 | Lee Kevin | BCYC | Ordinary Shares | D | 14.0000 | 35,446 | 496 | 290,180 | ||||
| 2021-07-14 | 2021-07-12 | 4 | Lee Kevin | BCYC | Stock Option (right to buy) | D | 14.00 | -1,936 | 412,608 | |||||
| 2021-07-14 | 2021-07-12 | 4 | Lee Kevin | BCYC | Ordinary Shares | D | 32.0400 | -1,936 | -62 | 254,734 | ||||
| 2021-07-14 | 2021-07-12 | 4 | Lee Kevin | BCYC | Ordinary Shares | D | 14.0000 | 1,936 | 27 | 256,670 | ||||
| 2021-07-14 | 2021-07-13 | 4 | Crockett Nigel | BCYC | Employee Stock Option (right to buy) | D | 15.36 | -13,019 | 30,764 | |||||
| 2021-07-14 | 2021-07-13 | 4 | Crockett Nigel | BCYC | Employee Stock Option (right to buy) | D | 9.82 | -19,256 | 38,750 | |||||
| 2021-07-14 | 2021-07-13 | 4 | Crockett Nigel | BCYC | Employee Stock Option (right to buy) | D | 11.66 | -40,426 | 62,660 | |||||
| 2021-07-14 | 2021-07-13 | 4 | Crockett Nigel | BCYC | Ordinary Shares | D | 33.0900 | -3,121 | -103 | 0 | ||||
| 2021-07-14 | 2021-07-13 | 4 | Crockett Nigel | BCYC | Ordinary Shares | D | 32.4100 | -69,580 | -2,255 | 3,121 | ||||
| 2021-07-14 | 2021-07-13 | 4 | Crockett Nigel | BCYC | Ordinary Shares | D | 15.3600 | 13,019 | 200 | 72,701 | ||||
| 2021-07-14 | 2021-07-13 | 4 | Crockett Nigel | BCYC | Ordinary Shares | D | 9.8200 | 19,256 | 189 | 59,682 | ||||
| 2021-07-14 | 2021-07-13 | 4 | Crockett Nigel | BCYC | Ordinary Shares | D | 11.6600 | 40,426 | 471 | 40,426 | ||||
| 2021-07-14 | 2021-07-12 | 4 | Crockett Nigel | BCYC | Employee Stock Option (right to buy) | D | 15.36 | -974 | 43,783 | |||||
| 2021-07-14 | 2021-07-12 | 4 | Crockett Nigel | BCYC | Employee Stock Option (right to buy) | D | 9.82 | -1,723 | 58,006 | |||||
| 2021-07-14 | 2021-07-12 | 4 | Crockett Nigel | BCYC | Employee Stock Option (right to buy) | D | 11.66 | -4,331 | 103,086 | |||||
| 2021-07-14 | 2021-07-12 | 4 | Crockett Nigel | BCYC | Ordinary Shares | D | 32.0300 | -7,028 | -225 | 0 | ||||
| 2021-07-14 | 2021-07-12 | 4 | Crockett Nigel | BCYC | Ordinary Shares | D | 15.3600 | 974 | 15 | 7,028 | ||||
| 2021-07-14 | 2021-07-12 | 4 | Crockett Nigel | BCYC | Ordinary Shares | D | 9.8200 | 1,723 | 17 | 6,054 | ||||
| 2021-07-14 | 2021-07-12 | 4 | Crockett Nigel | BCYC | Ordinary Shares | D | 11.6600 | 4,331 | 50 | 4,331 | ||||
| 2021-07-08 | 2021-07-06 | 4 | Crockett Nigel | BCYC | Employee Stock Option (right to buy) | D | 9.82 | -271 | 59,729 | |||||
| 2021-07-08 | 2021-07-06 | 4 | Crockett Nigel | BCYC | Ordinary Shares | D | 32.0000 | -271 | -9 | 0 | ||||
| 2021-07-08 | 2021-07-06 | 4 | Crockett Nigel | BCYC | Ordinary Shares | D | 9.8200 | 271 | 3 | 271 | ||||
| 2021-05-10 | 2021-05-07 | 4 | Lee Kevin | BCYC | Stock Option (right to buy) | D | 14.00 | -5,604 | 414,544 | |||||
| 2021-05-10 | 2021-05-07 | 4 | Lee Kevin | BCYC | Ordinary Shares | D | 32.2300 | -5,604 | -181 | 254,734 | ||||
| 2021-05-10 | 2021-05-07 | 4 | Lee Kevin | BCYC | Ordinary Shares | D | 14.0000 | 5,604 | 78 | 260,338 | ||||
| 2021-05-10 | 2021-05-06 | 4 | Lee Kevin | BCYC | Stock Option (right to buy) | D | 14.00 | -1,716 | 420,148 | |||||
| 2021-05-10 | 2021-05-06 | 4 | Lee Kevin | BCYC | Ordinary Shares | D | 32.1400 | -1,716 | -55 | 254,734 | ||||
| 2021-05-10 | 2021-05-06 | 4 | Lee Kevin | BCYC | Ordinary Shares | D | 14.0000 | 1,716 | 24 | 256,450 | ||||
| 2021-05-05 | 2021-05-04 | 4 | Lee Kevin | BCYC | Stock Option (right to buy) | D | 14.00 | -897 | 421,864 | |||||
| 2021-05-05 | 2021-05-04 | 4 | Lee Kevin | BCYC | Ordinary Shares | D | 32.0300 | -897 | -29 | 254,734 | ||||
| 2021-05-05 | 2021-05-04 | 4 | Lee Kevin | BCYC | Ordinary Shares | D | 14.0000 | 897 | 13 | 255,631 | ||||
| 2021-05-05 | 2021-05-03 | 4 | Lee Kevin | BCYC | Stock Option (right to buy) | D | 14.00 | -3,391 | 422,761 | |||||
| 2021-05-05 | 2021-05-03 | 4 | Lee Kevin | BCYC | Ordinary Shares | D | 32.1600 | -3,391 | -109 | 254,734 | ||||
| 2021-05-05 | 2021-05-03 | 4 | Lee Kevin | BCYC | Ordinary Shares | D | 14.0000 | 3,391 | 47 | 258,125 | ||||
| 2021-04-30 | 2021-04-30 | 4 | Lee Kevin | BCYC | Stock Option (Right to Buy) | D | 14.00 | -30,406 | 426,152 | |||||
| 2021-04-30 | 2021-04-30 | 4 | Lee Kevin | BCYC | Ordinary Shares | D | 30.8800 | -26,635 | -822 | 254,734 | ||||
| 2021-04-30 | 2021-04-30 | 4 | Lee Kevin | BCYC | Ordinary Shares | D | 29.8900 | -3,771 | -113 | 281,369 | ||||
| 2021-04-30 | 2021-04-30 | 4 | Lee Kevin | BCYC | Ordinary Shares | D | 14.0000 | 30,406 | 426 | 285,140 | ||||
| 2021-04-30 | 2021-04-29 | 4 | Lee Kevin | BCYC | Stock Option (Right to Buy) | D | 14.00 | -6,018 | 456,558 | |||||
| 2021-04-30 | 2021-04-29 | 4 | Lee Kevin | BCYC | Ordinary Shares | D | 30.9500 | -1,609 | -50 | 254,734 | ||||
| 2021-04-30 | 2021-04-29 | 4 | Lee Kevin | BCYC | Ordinary Shares | D | 30.3500 | -4,409 | -134 | 256,343 | ||||
| 2021-04-30 | 2021-04-29 | 4 | Lee Kevin | BCYC | Ordinary Shares | D | 14.0000 | 6,018 | 84 | 260,752 | ||||
| 2021-04-30 | 2021-04-28 | 4 | Lee Kevin | BCYC | Stock Option (Right to Buy) | D | 14.00 | -22,495 | 462,576 | |||||
| 2021-04-30 | 2021-04-28 | 4 | Lee Kevin | BCYC | Ordinary Shares | D | 33.3500 | -200 | -7 | 254,734 | ||||
| 2021-04-30 | 2021-04-28 | 4 | Lee Kevin | BCYC | Ordinary Shares | D | 32.3000 | -1,460 | -47 | 254,934 | ||||
| 2021-04-30 | 2021-04-28 | 4 | Lee Kevin | BCYC | Ordinary Shares | D | 31.2200 | -14,348 | -448 | 256,394 | ||||
| 2021-04-30 | 2021-04-28 | 4 | Lee Kevin | BCYC | Ordinary Shares | D | 30.4300 | -6,487 | -197 | 270,742 | ||||
| 2021-04-30 | 2021-04-28 | 4 | Lee Kevin | BCYC | Ordinary Shares | D | 14.0000 | 22,495 | 315 | 277,229 | ||||
| 2021-04-28 | 2021-04-27 | 4 | Lee Kevin | BCYC | Ordinary Shares | D | 31.4100 | -358 | -11 | 254,734 | ||||
| 2021-04-28 | 2021-04-27 | 4 | Lee Kevin | BCYC | Ordinary Shares | D | 30.6600 | -6,278 | -192 | 255,092 | ||||
| 2021-04-28 | 2021-04-27 | 4 | Lee Kevin | BCYC | Ordinary Shares | D | 14.0000 | 6,636 | 93 | 261,370 | ||||
| 2021-04-28 | 2021-04-26 | 4 | Lee Kevin | BCYC | Stock Option (Right to Buy) | D | 14.00 | -6,636 | 485,071 | |||||
| 2021-04-28 | 2021-04-26 | 4 | Lee Kevin | BCYC | Stock Option (Right to Buy) | D | 14.00 | -14,545 | 491,707 | |||||
| 2021-04-28 | 2021-04-26 | 4 | Lee Kevin | BCYC | Ordinary Shares | D | 31.5000 | -13,896 | -438 | 254,734 | ||||
| 2021-04-28 | 2021-04-26 | 4 | Lee Kevin | BCYC | Ordinary Shares | D | 30.6300 | -4,715 | -144 | 268,630 | ||||
| 2021-04-28 | 2021-04-26 | 4 | Lee Kevin | BCYC | Ordinary Shares | D | 14.0000 | 14,545 | 204 | 273,345 | ||||
| 2021-04-09 | 2021-04-08 | 4 | Legault Pierre | BCYC | Stock Option (Right to Buy) | D | 8.74 | -24,838 | 173,312 | |||||
| 2021-04-09 | 2021-04-08 | 4 | Legault Pierre | BCYC | Ordinary Shares | D | 32.1300 | -239 | -8 | 0 | ||||
| 2021-04-09 | 2021-04-08 | 4 | Legault Pierre | BCYC | Ordinary Shares | D | 31.4000 | -12,099 | -380 | 239 | ||||
| 2021-04-09 | 2021-04-08 | 4 | Legault Pierre | BCYC | Ordinary Shares | D | 32.0000 | -12,500 | -400 | 12,338 | ||||
| 2021-04-09 | 2021-04-08 | 4 | Legault Pierre | BCYC | Ordinary Shares | D | 8.7400 | 24,838 | 217 | 24,838 | ||||
| 2021-04-07 | 2021-04-05 | 4 | Legault Pierre | BCYC | Stock Option (Right to Buy) | D | 8.83 | -162 | 198,150 | |||||
| 2021-04-07 | 2021-04-05 | 4 | Legault Pierre | BCYC | Ordinary Shares | D | 31.0700 | -162 | -5 | 0 | ||||
| 2021-04-07 | 2021-04-05 | 4 | Legault Pierre | BCYC | Ordinary Shares | D | 8.8300 | 162 | 1 | 162 | ||||
| 2021-04-02 | 2021-03-31 | 4 | Keen Nicholas | BCYC | Ordinary Shares | D | 30.0000 | -10,000 | -300 | 28,321 | ||||
| 2021-04-02 | 2021-03-31 | 4 | Legault Pierre | BCYC | Stock Option (Right to Buy) | D | 8.78 | -10,000 | 198,312 | |||||
| 2021-04-02 | 2021-03-31 | 4 | Legault Pierre | BCYC | Ordinary Shares | D | 30.0000 | -10,000 | -300 | 0 | ||||
| 2021-04-02 | 2021-03-31 | 4 | Legault Pierre | BCYC | Ordinary Shares | D | 8.7800 | 10,000 | 88 | 10,000 | ||||
| 2021-03-19 | 2021-03-17 | 4 | Gutierrez-Ramos Jose-Carlos | BCYC | Stock Option (right to buy) | D | 27.90 | 32,000 | 32,000 | |||||
| 2021-03-19 | 2021-03-17 | 4 | Legault Pierre | BCYC | Stock Option (Right to Buy) | D | 8.85 | -7,784 | 208,312 | |||||
| 2021-03-19 | 2021-03-17 | 4 | Legault Pierre | BCYC | Ordinary Shares | D | 29.0000 | -7,784 | -226 | 0 | ||||
| 2021-03-19 | 2021-03-17 | 4 | Legault Pierre | BCYC | Ordinary Shares | D | 8.8500 | 7,784 | 69 | 7,784 | ||||
| 2021-03-16 | 2021-03-12 | 4 | Legault Pierre | BCYC | Stock Option (Right to Buy) | D | 8.86 | -2,216 | 216,096 | |||||
| 2021-03-16 | 2021-03-12 | 4 | Legault Pierre | BCYC | Ordinary Shares | D | 29.0000 | -2,216 | -64 | 0 | ||||
| 2021-03-16 | 2021-03-12 | 4 | Legault Pierre | BCYC | Ordinary Shares | D | 8.8600 | 2,216 | 20 | 2,216 | ||||
| 2021-03-16 | 2021-03-15 | 4 | Keen Nicholas | BCYC | Ordinary Shares | D | 28.0000 | -217 | -6 | 38,321 | ||||
| 2021-03-16 | 2021-03-12 | 4 | Keen Nicholas | BCYC | Ordinary Shares | D | 29.0000 | -283 | -8 | 38,538 | ||||
| 2021-03-16 | 2021-03-12 | 4 | Keen Nicholas | BCYC | Ordinary Shares | D | 28.4800 | -9,500 | -271 | 38,821 | ||||
| 2021-02-09 | 2021-02-05 | 4 | Lee Kevin | BCYC | Ordinary Shares | D | 31.0000 | -100 | -3 | 258,800 | ||||
| 2021-01-21 | 2021-01-20 | 4 | Lee Kevin | BCYC | Ordinary Shares | D | 33.0000 | -351 | -12 | 258,900 | ||||
| 2021-01-21 | 2021-01-20 | 4 | Lee Kevin | BCYC | Ordinary Shares | D | 32.0200 | -100 | -3 | 259,251 | ||||
| 2021-01-21 | 2021-01-20 | 4 | Lee Kevin | BCYC | Ordinary Shares | D | 31.3272 | -734 | -23 | 259,351 | ||||
| 2021-01-21 | 2021-01-19 | 4 | Lee Kevin | BCYC | Ordinary Shares | D | 31.0900 | -100 | -3 | 260,085 | ||||
| 2021-01-21 | 2021-01-19 | 4 | Lee Kevin | BCYC | Ordinary Shares | D | 30.2193 | -371 | -11 | 260,185 | ||||
| 2021-01-21 | 2021-01-19 | 4 | Lee Kevin | BCYC | Ordinary Shares | D | 29.1389 | -4,529 | -132 | 260,556 | ||||
| 2021-01-21 | 2021-01-19 | 4 | Kalowski Lee | BCYC | Stock Option (Right to Buy) | D | 1.59 | -15,000 | 79,774 | |||||
| 2021-01-21 | 2021-01-19 | 4 | Kalowski Lee | BCYC | Ordinary Shares | D | 30.0000 | -15,000 | -450 | 0 | ||||
| 2021-01-21 | 2021-01-19 | 4 | Kalowski Lee | BCYC | Ordinary Shares | D | 1.5900 | 15,000 | 24 | 15,000 | ||||
| 2021-01-15 | 2021-01-14 | 4 | Kalowski Lee | BCYC | Stock Option (Right to Buy) | D | 1.60 | -10,000 | 94,774 | |||||
| 2021-01-15 | 2021-01-14 | 4 | Kalowski Lee | BCYC | Ordinary Shares | D | 25.0000 | -10,000 | -250 | 0 | ||||
| 2021-01-15 | 2021-01-14 | 4 | Kalowski Lee | BCYC | Ordinary Shares | D | 1.6000 | 10,000 | 16 | 10,000 | ||||
| 2021-01-15 | 2021-01-15 | 4 | Lee Kevin | BCYC | Ordinary Shares | D | 27.0100 | -5,000 | -135 | 265,085 | ||||
| 2021-01-15 | 2021-01-14 | 4 | Lee Kevin | BCYC | Ordinary Shares | D | 25.0000 | -5,000 | -125 | 270,085 | ||||
| 2021-01-05 | 2021-01-04 | 4 | Winter Gregory Paul | BCYC | Stock Option (right to buy) | D | 17.95 | 19,000 | 19,000 | |||||
| 2021-01-05 | 2021-01-04 | 4 | Smethurst Dominic | BCYC | Employee Stock Option (right to buy) | D | 17.95 | 27,621 | 27,621 | |||||
| 2021-01-05 | 2021-01-04 | 4 | Skynner Michael | BCYC | Employee Stock Option (right to buy) | D | 17.95 | 70,500 | 70,500 | |||||
| 2021-01-05 | 2021-01-04 | 4 | Legault Pierre | BCYC | Stock Option (right to buy) | D | 17.95 | 38,000 | 38,000 | |||||
| 2021-01-05 | 2021-01-04 | 4 | Lee Kevin | BCYC | Employee Stock Option (right to buy) | D | 17.95 | 250,000 | 250,000 | |||||
| 2021-01-05 | 2021-01-04 | 4 | Kender Richard N | BCYC | Stock Option (right to buy) | D | 17.95 | 19,000 | 19,000 | |||||
| 2021-01-05 | 2021-01-04 | 4 | Keen Nicholas | BCYC | Employee Stock Option (right to buy) | D | 17.95 | 70,500 | 70,500 | |||||
| 2021-01-05 | 2021-01-04 | 4 | Kalowski Lee | BCYC | Employee Stock Option (right to buy) | D | 17.95 | 70,500 | 70,500 | |||||
| 2021-01-05 | 2021-01-04 | 4 | Jordan Veronica GH | BCYC | Stock Option (right to buy) | D | 17.95 | 19,000 | 19,000 | |||||
| 2021-01-05 | 2021-01-04 | 4 | Crockett Nigel | BCYC | Employee Stock Option (right to buy) | D | 17.95 | 70,500 | 70,500 | |||||
| 2021-01-05 | 2021-01-04 | 4 | Bourque Janice | BCYC | Stock Option (right to buy) | D | 17.95 | 19,000 | 19,000 | |||||
| 2021-01-05 | 2021-01-04 | 4 | BINGHAM KATE | BCYC | Stock Option (right to buy) | D | 17.95 | 19,000 | 19,000 | |||||
| 2020-12-03 | 2020-12-01 | 4 | Kalowski Lee | BCYC | Stock Option (Right to Buy) | D | 1.56 | -7,500 | 104,774 | |||||
| 2020-12-03 | 2020-12-01 | 4 | Kalowski Lee | BCYC | Ordinary Shares | D | 22.5000 | -7,500 | -169 | 0 | ||||
| 2020-12-03 | 2020-12-01 | 4 | Kalowski Lee | BCYC | Ordinary Shares | D | 1.5600 | 7,500 | 12 | 7,500 | ||||
| 2020-11-30 | 2020-11-27 | 4 | Kalowski Lee | BCYC | Stock Option (Right to Buy) | D | 1.56 | -530 | 112,274 | |||||
| 2020-11-30 | 2020-11-27 | 4 | Kalowski Lee | BCYC | Ordinary Shares | D | 20.0000 | -530 | -11 | 0 | ||||
| 2020-11-30 | 2020-11-27 | 4 | Kalowski Lee | BCYC | Ordinary Shares | D | 1.5600 | 530 | 1 | 530 | ||||
| 2020-11-25 | 2020-11-25 | 4 | Kalowski Lee | BCYC | Stock Option (Right to Buy) | D | 1.56 | -9,781 | 112,804 | |||||
| 2020-11-25 | 2020-11-25 | 4 | Kalowski Lee | BCYC | Ordinary Shares | D | 20.0700 | -9,781 | -196 | 0 | ||||
| 2020-11-25 | 2020-11-25 | 4 | Kalowski Lee | BCYC | Ordinary Shares | D | 1.5600 | 9,781 | 15 | 9,781 | ||||
| 2020-11-25 | 2020-11-23 | 4 | Kalowski Lee | BCYC | Stock Option (Right to Buy) | D | 1.56 | -17,189 | 122,585 | |||||
| 2020-11-25 | 2020-11-23 | 4 | Kalowski Lee | BCYC | Ordinary Shares | D | 20.3800 | -213 | -4 | 0 | ||||
| 2020-11-25 | 2020-11-23 | 4 | Kalowski Lee | BCYC | Ordinary Shares | D | 19.8200 | -16,976 | -336 | 213 | ||||
| 2020-11-25 | 2020-11-23 | 4 | Kalowski Lee | BCYC | Ordinary Shares | D | 1.5600 | 17,189 | 27 | 17,189 | ||||
| 2020-09-18 | 2020-07-15 | 4 | GLAXOSMITHKLINE PLC | BCYC | Common Stock | I | 19.2500 | -78 | -2 | 1,910,531 | ||||
| 2020-09-18 | 2020-07-15 | 4 | GLAXOSMITHKLINE PLC | BCYC | Common Stock | I | 19.4016 | -3,069 | -60 | 1,910,609 | ||||
| 2020-09-18 | 2020-07-14 | 4 | GLAXOSMITHKLINE PLC | BCYC | Common Stock | I | 19.2740 | -1,597 | -31 | 1,913,678 | ||||
| 2020-08-25 | 2020-08-21 | 4 | Smethurst Dominic | BCYC | Employee Stock Option (right to buy) | D | 18.55 | 120,000 | 120,000 | |||||
| 2020-04-27 | 2019-06-28 | 4/A | Keen Nicholas | BCYC | Stock Option (Right to Buy) | D | 14.00 | 177,404 | 177,404 | |||||
| 2020-04-27 | 2019-06-28 | 4/A | Kalowski Lee | BCYC | Stock Option (Right to Buy) | D | 14.00 | 283,414 | 283,414 | |||||
| 2020-04-27 | 2019-06-28 | 4/A | Skynner Michael | BCYC | Stock Option (Right to Buy) | D | 14.00 | 183,895 | 183,895 | |||||
| 2020-04-27 | 2019-06-28 | 4/A | Lee Kevin | BCYC | Stock Option (Right to Buy) | D | 14.00 | 506,252 | 506,252 | |||||
| 2020-04-27 | 2019-06-28 | 4/A | Legault Pierre | BCYC | Stock Option (Right to Buy) | D | 14.00 | 116,827 | 116,827 | |||||
| 2020-04-16 | 2020-04-14 | 4 | Winter Gregory Paul | BCYC | Series A Preferred Shares Warrant | D | -71,450 | 71,450 | ||||||
| 2020-04-16 | 2020-04-14 | 4 | Winter Gregory Paul | BCYC | Ordinary Shares | D | 71,450 | 163,927 | ||||||
| 2020-02-25 | 2020-02-21 | 4 | Crockett Nigel | BCYC | Employee Stock Option (right to buy) | D | 15.36 | 44,757 | 44,757 | |||||
| 2020-01-06 | 2019-09-26 | 4/A | Crockett Nigel | BCYC | Employee Stock Option (Right to Buy) | D | 11.66 | 107,417 | 107,417 | |||||
| 2020-01-06 | 2020-01-02 | 4 | Kender Richard N | BCYC | Stock Option (right to buy) | D | 9.82 | 8,202 | 8,202 | |||||
| 2020-01-06 | 2020-01-02 | 4 | Kender Richard N | BCYC | Stock Option (right to buy) | D | 9.82 | 16,000 | 16,000 | |||||
| 2020-01-06 | 2020-01-02 | 4 | Legault Pierre | BCYC | Stock Option (right to buy) | D | 9.82 | 32,000 | 32,000 | |||||
| 2020-01-06 | 2020-01-02 | 4 | Bourque Janice | BCYC | Stock Option (right to buy) | D | 9.82 | 8,202 | 8,202 | |||||
| 2020-01-06 | 2020-01-02 | 4 | Bourque Janice | BCYC | Stock Option (right to buy) | D | 9.82 | 16,000 | 16,000 | |||||
| 2020-01-06 | 2020-01-02 | 4 | Crockett Nigel | BCYC | Employee Stock Option (right to buy) | D | 9.82 | 60,000 | 60,000 | |||||
| 2020-01-06 | 2020-01-02 | 4 | Jordan Veronica GH | BCYC | Stock Option (right to buy) | D | 9.82 | 16,000 | 16,000 | |||||
| 2020-01-06 | 2020-01-02 | 4 | Keen Nicholas | BCYC | Employee Stock Option (right to buy) | D | 9.82 | 60,000 | 60,000 | |||||
| 2020-01-06 | 2020-01-02 | 4 | Kalowski Lee | BCYC | Employee Stock Option (right to buy) | D | 9.82 | 60,000 | 60,000 | |||||
| 2020-01-06 | 2020-01-02 | 4 | Skynner Michael | BCYC | Employee Stock Option (right to buy) | D | 9.82 | 60,000 | 60,000 | |||||
| 2020-01-06 | 2020-01-02 | 4 | Lee Kevin | BCYC | Employee Stock Option (right to buy) | D | 9.82 | 210,000 | 210,000 | |||||
| 2020-01-06 | 2020-01-02 | 4 | Winter Gregory Paul | BCYC | Stock Option (right to buy) | D | 9.82 | 16,000 | 16,000 | |||||
| 2020-01-06 | 2020-01-02 | 4 | BINGHAM KATE | BCYC | Stock Option (right to buy) | D | 9.82 | 16,000 | 16,000 | |||||
| 2019-12-19 | 2019-12-17 | 4 | Jordan Veronica GH | BCYC | Stock Option (right to buy) | D | 8.30 | 32,000 | 32,000 | |||||
| 2019-09-30 | 2019-09-26 | 4 | Bourque Janice | BCYC | Stock Option (Right to Buy) | D | 11.66 | 23,798 | 23,798 | |||||
| 2019-09-30 | 2019-09-26 | 4 | Crockett Nigel | BCYC | Employee Stock Option (Right to Buy) | D | 11.66 | 152,174 | 152,174 | |||||
| 2019-09-30 | 2019-09-26 | 4 | Kender Richard N | BCYC | Stock Option (Right to Buy) | D | 11.66 | 23,798 | 23,798 | |||||
| 2019-06-03 | 2019-05-28 | 4 | TYBOURNE CAPITAL MANAGEMENT HK LTD See Footnotes | BCYC | Series B2 Preferred Shares Warrants | I | -139,264 | 0 | ||||||
| 2019-06-03 | 2019-05-28 | 4 | TYBOURNE CAPITAL MANAGEMENT HK LTD See Footnotes | BCYC | Ordinary Shares | I | 14.0000 | 364,286 | 5,100 | 1,957,961 | ||||
| 2019-06-03 | 2019-05-28 | 4 | TYBOURNE CAPITAL MANAGEMENT HK LTD See Footnotes | BCYC | Ordinary Shares | I | 139,264 | 1,593,675 | ||||||
| 2019-06-03 | 2019-05-28 | 4 | TYBOURNE CAPITAL MANAGEMENT HK LTD See Footnotes | BCYC | Ordinary Shares | I | 1,454,411 | 1,454,411 | ||||||
| 2019-06-03 | 2019-05-24 | 4 | TYBOURNE CAPITAL MANAGEMENT HK LTD See Footnotes | BCYC | Series B2 Preferred Shares | I | -1,454,411 | 0 | ||||||
| 2019-05-31 | 2019-05-28 | 4/A | NG CAROLYN By Vertex Global Healthcare Fund I PTE. LTD | BCYC | Series B2 Preferred Shares | I | -206,767 | 0 | ||||||
| 2019-05-31 | 2019-05-28 | 4/A | NG CAROLYN By Vertex Global Healthcare Fund I PTE. LTD | BCYC | Series B1 Preferred Shares Warrants | I | -141,668 | 0 | ||||||
| 2019-05-31 | 2019-05-28 | 4/A | NG CAROLYN By Vertex Global Healthcare Fund I PTE. LTD | BCYC | Series B1 Preferred Shares | I | -1,272,733 | 0 | ||||||
| 2019-05-31 | 2019-05-28 | 4/A | NG CAROLYN By Vertex Global Healthcare Fund I PTE. LTD | BCYC | Ordinary Shares | I | 206,767 | 1,427,151 | ||||||
| 2019-05-31 | 2019-05-28 | 4/A | NG CAROLYN By Vertex Global Healthcare Fund I PTE. LTD | BCYC | Ordinary Shares | I | 141,668 | 1,207,410 | ||||||
| 2019-05-31 | 2019-05-28 | 4/A | NG CAROLYN By Vertex Global Healthcare Fund I PTE. LTD | BCYC | Ordinary Shares | I | 1,272,733 | 1,081,823 | ||||||
| 2019-05-31 | 2019-05-29 | 4 | Cambridge Innovation Capital (Jersey) Ltd | BCYC | Ordinary Shares | D | 14.0000 | 314,286 | 4,400 | 1,751,437 | ||||
| 2019-05-31 | 2019-05-28 | 4 | Cambridge Innovation Capital (Jersey) Ltd | BCYC | Series B2 Preferred Shares | D | -229,741 | 0 | ||||||
| 2019-05-31 | 2019-05-28 | 4 | Cambridge Innovation Capital (Jersey) Ltd | BCYC | Series B1 Preferred Shares Warrants | D | -125,587 | 0 | ||||||
| 2019-05-31 | 2019-05-28 | 4 | Cambridge Innovation Capital (Jersey) Ltd | BCYC | Series B1 Preferred Shares | D | -1,081,823 | 0 | ||||||
| 2019-05-31 | 2019-05-28 | 4 | Cambridge Innovation Capital (Jersey) Ltd | BCYC | Ordinary Shares | D | 229,741 | 1,437,151 | ||||||
| 2019-05-31 | 2019-05-28 | 4 | Cambridge Innovation Capital (Jersey) Ltd | BCYC | Ordinary Shares | D | 125,587 | 1,207,410 | ||||||
| 2019-05-31 | 2019-05-28 | 4 | Cambridge Innovation Capital (Jersey) Ltd | BCYC | Ordinary Shares | D | 1,081,823 | 1,081,823 | ||||||
| 2019-05-30 | 2019-05-28 | 4 | Vertex Global Healthcare Fund I Pte Ltd. | BCYC | Series B2 Preferred Shares | D | -206,767 | 0 | ||||||
| 2019-05-30 | 2019-05-28 | 4 | Vertex Global Healthcare Fund I Pte Ltd. | BCYC | Series B1 Preferred Shares Warrants | D | -141,668 | 0 | ||||||
| 2019-05-30 | 2019-05-28 | 4 | Vertex Global Healthcare Fund I Pte Ltd. | BCYC | Series B1 Preferred Shares | D | -1,272,733 | 0 | ||||||
| 2019-05-30 | 2019-05-28 | 4 | Vertex Global Healthcare Fund I Pte Ltd. | BCYC | Ordinary Shares | D | 206,767 | 1,621,168 | ||||||
| 2019-05-30 | 2019-05-28 | 4 | Vertex Global Healthcare Fund I Pte Ltd. | BCYC | Ordinary Shares | D | 141,668 | 1,414,401 | ||||||
| 2019-05-30 | 2019-05-28 | 4 | Vertex Global Healthcare Fund I Pte Ltd. | BCYC | Ordinary Shares | D | 1,272,733 | 1,272,733 | ||||||
| 2019-05-30 | 2019-05-28 | 4 | Keen Nicholas | BCYC | Stock Option (Right to Buy) | D | 14.00 | 177,404 | 177,404 | |||||
| 2019-05-30 | 2019-05-28 | 4 | Skynner Michael | BCYC | Stock Option (Right to Buy) | D | 14.00 | 183,895 | 183,895 | |||||
| 2019-05-30 | 2019-05-28 | 4 | Kalowski Lee | BCYC | Stock Option (Right to Buy) | D | 14.00 | 283,414 | 283,414 | |||||
| 2019-05-30 | 2019-05-28 | 4 | Leone Peter Brian | BCYC | Stock Option (Right to Buy) | D | 14.00 | 43,269 | 43,269 | |||||
| 2019-05-30 | 2019-05-28 | 4 | Lee Kevin | BCYC | Stock Option (Right to Buy) | D | 14.00 | 506,252 | 506,252 | |||||
| 2019-05-30 | 2019-05-28 | 4 | Legault Pierre | BCYC | Stock Option (Right to Buy) | D | 14.00 | 116,827 | 116,827 | |||||
| 2019-05-30 | 2019-05-28 | 4 | HARLAND DEBORAH | BCYC | Series B1 Preferred Shares | I | -636,366 | 0 | ||||||
| 2019-05-30 | 2019-05-28 | 4 | HARLAND DEBORAH | BCYC | Series A Preferred Shares | I | -893,195 | 0 | ||||||
| 2019-05-30 | 2019-05-28 | 4 | HARLAND DEBORAH | BCYC | Ordinary Shares | I | 14.0000 | 385,714 | 5,400 | 1,915,275 | ||||
| 2019-05-30 | 2019-05-28 | 4 | HARLAND DEBORAH | BCYC | Ordinary Shares | I | 636,366 | 1,529,561 | ||||||
| 2019-05-30 | 2019-05-28 | 4 | HARLAND DEBORAH | BCYC | Ordinary Shares | I | 893,195 | 893,195 | ||||||
| 2019-05-30 | 2019-05-28 | 4 | BINGHAM KATE By SV Life Sciences Fund V Strategic Partners. L.P. | BCYC | Series B1 Preferred Shares | I | -13,169 | 0 | ||||||
| 2019-05-30 | 2019-05-28 | 4 | BINGHAM KATE By SV Life Sciences Fund V Strategic Partners. L.P. | BCYC | Series A Preferred Shares | I | -18,485 | 0 | ||||||
| 2019-05-30 | 2019-05-28 | 4 | BINGHAM KATE By SV Life Sciences Fund V, L.P. | BCYC | Series B1 Preferred Shares | I | -623,196 | 0 | ||||||
| 2019-05-30 | 2019-05-28 | 4 | BINGHAM KATE By SV Life Sciences Fund V, L.P. | BCYC | Series A Preferred Shares | I | -874,709 | 0 | ||||||
| 2019-05-30 | 2019-05-28 | 4 | BINGHAM KATE By SV Life Sciences Fund V Strategic Partners. L.P. | BCYC | Ordinary Shares | I | 14.0000 | 7,983 | 112 | 39,637 | ||||
| 2019-05-30 | 2019-05-28 | 4 | BINGHAM KATE By SV Life Sciences Fund V, L.P. | BCYC | Ordinary Shares | I | 14.0000 | 377,732 | 5,288 | 1,875,637 | ||||
| 2019-05-30 | 2019-05-28 | 4 | BINGHAM KATE By SV Life Sciences Fund V Strategic Partners. L.P. | BCYC | Ordinary Shares | I | 13,169 | 31,654 | ||||||
| 2019-05-30 | 2019-05-28 | 4 | BINGHAM KATE By SV Life Sciences Fund V Strategic Partners. L.P. | BCYC | Ordinary Shares | I | 18,485 | 18,485 | ||||||
| 2019-05-30 | 2019-05-28 | 4 | BINGHAM KATE By SV Life Sciences Fund V, L.P. | BCYC | Ordinary Shares | I | 623,196 | 1,497,905 | ||||||
| 2019-05-30 | 2019-05-28 | 4 | BINGHAM KATE By SV Life Sciences Fund V, L.P. | BCYC | Ordinary Shares | I | 874,709 | 874,709 | ||||||
| 2019-05-30 | 2019-05-28 | 4 | Anstey Michael By Cambridge Innovation Capital (Jersey) Limited | BCYC | Series B2 Preferred Shares | I | 229,741 | 0 | ||||||
| 2019-05-30 | 2019-05-28 | 4 | Anstey Michael By Cambridge Innovation Capital (Jersey) Limited | BCYC | Series B1 Preferred Shares Warrants | I | 125,587 | 0 | ||||||
| 2019-05-30 | 2019-05-28 | 4 | Anstey Michael By Cambridge Innovation Capital (Jersey) Limited | BCYC | Series B1 Preferred Shares | I | 1,081,823 | 0 | ||||||
| 2019-05-30 | 2019-05-28 | 4 | Anstey Michael By Cambridge Innovation Capital (Jersey) Limited | BCYC | Ordinary Shares | I | 14.0000 | 314,286 | 4,400 | 1,751,437 | ||||
| 2019-05-30 | 2019-05-28 | 4 | Anstey Michael By Cambridge Innovation Capital (Jersey) Limited | BCYC | Ordinary Shares | I | 229,741 | 1,437,151 | ||||||
| 2019-05-30 | 2019-05-28 | 4 | Anstey Michael By Cambridge Innovation Capital (Jersey) Limited | BCYC | Ordinary Shares | I | 125,587 | 1,207,410 | ||||||
| 2019-05-30 | 2019-05-28 | 4 | Anstey Michael By Cambridge Innovation Capital (Jersey) Limited | BCYC | Ordinary Shares | I | 1,081,823 | 1,081,823 | ||||||
| 2019-05-30 | 2019-05-28 | 4 | SVLSF V, LLC By SV Life Sciences Fund V Strategic Partners. L.P. | BCYC | Series B1 Preferred Shares | I | -13,169 | 0 | ||||||
| 2019-05-30 | 2019-05-28 | 4 | SVLSF V, LLC By SV Life Sciences Fund V Strategic Partners. L.P. | BCYC | Series A Preferred Shares | I | -18,485 | 0 | ||||||
| 2019-05-30 | 2019-05-28 | 4 | SVLSF V, LLC By SV Life Sciences Fund V, L.P. | BCYC | Series B1 Preferred Shares | I | -623,196 | 0 | ||||||
| 2019-05-30 | 2019-05-28 | 4 | SVLSF V, LLC By SV Life Sciences Fund V, L.P. | BCYC | Series A Preferred Shares | I | -874,709 | 0 | ||||||
| 2019-05-30 | 2019-05-28 | 4 | SVLSF V, LLC By SV Life Sciences Fund V Strategic Partners. L.P. | BCYC | Ordinary Shares | I | 14.0000 | 7,983 | 112 | 39,637 | ||||
| 2019-05-30 | 2019-05-28 | 4 | SVLSF V, LLC By SV Life Sciences Fund V, L.P. | BCYC | Ordinary Shares | I | 14.0000 | 377,732 | 5,288 | 1,875,637 | ||||
| 2019-05-30 | 2019-05-28 | 4 | SVLSF V, LLC By SV Life Sciences Fund V Strategic Partners. L.P. | BCYC | Ordinary Shares | I | 13,169 | 31,654 | ||||||
| 2019-05-30 | 2019-05-28 | 4 | SVLSF V, LLC By SV Life Sciences Fund V Strategic Partners. L.P. | BCYC | Ordinary Shares | I | 18,485 | 18,485 | ||||||
| 2019-05-30 | 2019-05-28 | 4 | SVLSF V, LLC By SV Life Sciences Fund V, L.P. | BCYC | Ordinary Shares | I | 623,196 | 1,497,905 | ||||||
| 2019-05-30 | 2019-05-28 | 4 | SVLSF V, LLC By SV Life Sciences Fund V, L.P. | BCYC | Ordinary Shares | I | 874,709 | 874,709 | ||||||
| 2019-05-30 | 2019-05-28 | 4 | NG CAROLYN By Vertex Global Healthcare Fund I PTE. LTD | BCYC | Series B2 Preferred Shares | I | -206,767 | 0 | ||||||
| 2019-05-30 | 2019-05-28 | 4 | NG CAROLYN By Vertex Global Healthcare Fund I PTE. LTD | BCYC | Series B1 Preferred Shares Warrants | I | -141,668 | 0 | ||||||
| 2019-05-30 | 2019-05-28 | 4 | NG CAROLYN By Vertex Global Healthcare Fund I PTE. LTD | BCYC | Series B1 Preferred Shares | I | -1,272,733 | 0 | ||||||
| 2019-05-30 | 2019-05-28 | 4 | NG CAROLYN By Vertex Global Healthcare Fund I PTE. LTD | BCYC | Ordinary Shares | I | 206,767 | 1,621,168 | ||||||
| 2019-05-30 | 2019-05-28 | 4 | NG CAROLYN By Vertex Global Healthcare Fund I PTE. LTD | BCYC | Ordinary Shares | I | 141,668 | 1,414,401 | ||||||
| 2019-05-30 | 2019-05-28 | 4 | NG CAROLYN By Vertex Global Healthcare Fund I PTE. LTD | BCYC | Ordinary Shares | I | 1,272,733 | 1,272,733 | ||||||
| 2019-05-30 | 2019-05-27 | 4 | NG CAROLYN By Vertex Venture Management PTE LTD. | BCYC | Ordinary Shares | I | 14.0000 | 571,429 | 8,000 | 571,429 | ||||
| 2019-05-30 | 2019-05-28 | 4 | Winter Gregory Paul | BCYC | Series A Preferred Shares | D | -42,870 | 0 | ||||||
| 2019-05-30 | 2019-05-28 | 4 | Winter Gregory Paul | BCYC | Ordinary Shares | D | 42,870 | 92,477 | ||||||
| 2019-05-30 | 2019-05-28 | 4 | Novartis Bioventures Ltd | BCYC | Series B1 Preferred Shares | D | -636,366 | 0 | ||||||
| 2019-05-30 | 2019-05-28 | 4 | Novartis Bioventures Ltd | BCYC | Series A Preferred Shares Warrants | D | -71,450 | 0 | ||||||
| 2019-05-30 | 2019-05-28 | 4 | Novartis Bioventures Ltd | BCYC | Series A Preferred Shares | D | -893,195 | 0 | ||||||
| 2019-05-30 | 2019-05-28 | 4 | Novartis Bioventures Ltd | BCYC | Ordinary Shares | D | 14.0000 | 168,630 | 2,361 | 1,769,641 | ||||
| 2019-05-30 | 2019-05-28 | 4 | Novartis Bioventures Ltd | BCYC | Ordinary Shares | D | 636,366 | 1,601,011 | ||||||
| 2019-05-30 | 2019-05-28 | 4 | Novartis Bioventures Ltd | BCYC | Ordinary Shares | D | 71,450 | 964,645 | ||||||
| 2019-05-30 | 2019-05-28 | 4 | Novartis Bioventures Ltd | BCYC | Ordinary Shares | D | 893,195 | 893,195 | ||||||
| 2019-05-30 | 2019-05-28 | 4 | GLAXOSMITHKLINE PLC | BCYC | Series B1 Preferred Shares | I | -445,323 | 0 | ||||||
| 2019-05-30 | 2019-05-28 | 4 | GLAXOSMITHKLINE PLC | BCYC | Series A Preferred Shares | I | -625,049 | 0 | ||||||
| 2019-05-30 | 2019-05-28 | 4 | GLAXOSMITHKLINE PLC | BCYC | Ordinary Shares | I | 14.0000 | 385,714 | 5,400 | 1,915,275 | ||||
| 2019-05-30 | 2019-05-28 | 4 | GLAXOSMITHKLINE PLC | BCYC | Ordinary Shares | I | 636,366 | 1,529,561 | ||||||
| 2019-05-30 | 2019-05-28 | 4 | GLAXOSMITHKLINE PLC | BCYC | Ordinary Shares | I | 893,195 | 893,195 | ||||||
| 2019-05-22 | 3 | Skynner Michael | BCYC | Ordinary Shares | D | 82,246 | ||||||||
| 2019-05-22 | 3 | Skynner Michael | BCYC | Ordinary Shares | D | 82,246 | ||||||||
| 2019-05-22 | 3 | Skynner Michael | BCYC | Ordinary Shares | D | 82,246 | ||||||||
| 2019-05-22 | 3 | Lee Kevin | BCYC | Ordinary Shares | D | 550,170 | ||||||||
| 2019-05-22 | 3 | Lee Kevin | BCYC | Ordinary Shares | D | 550,170 | ||||||||
| 2019-05-22 | 3 | Lee Kevin | BCYC | Ordinary Shares | D | 550,170 | ||||||||
| 2019-05-22 | 3 | Keen Nicholas | BCYC | Ordinary Shares | D | 96,642 | ||||||||
| 2019-05-22 | 3 | Keen Nicholas | BCYC | Ordinary Shares | D | 96,642 | ||||||||
| 2019-05-22 | 3 | Keen Nicholas | BCYC | Ordinary Shares | D | 96,642 | ||||||||
| 2019-05-22 | 3 | Winter Gregory Paul | BCYC | Ordinary Shares | D | 99,214 | ||||||||
| 2019-05-22 | 3 | Winter Gregory Paul | BCYC | Ordinary Shares | D | 99,214 | ||||||||
| 2019-05-22 | 3 | Winter Gregory Paul | BCYC | Ordinary Shares | D | 99,214 |
P
Pembelian sekuritas non-derivatif atau derivatif di pasar terbuka atau secara pribadi.
S
Penjualan terbuka atau penjualan pribadi atas sekuritas non-derivatif atau derivatif.
A
Hibah, penghargaan, atau perolehan sekuritas lainnya dari perusahaan (seperti opsi)
C
Konversi turunan
D
Penjualan atau pengalihan sekuritas kembali ke perusahaan.
F
Pembayaran harga pelaksanaan atau kewajiban pajak menggunakan sebagian sekuritas yang diterima dari perusahaan.
G
Pemberian sekuritas oleh atau kepada orang dalam.
K
Swap ekuitas dan transaksi lindung nilai serupa
M
Pelaksanaan atau konversi sekuritas derivatif yang diterima dari perusahaan (seperti opsi)
V
Transaksi yang dilaporkan secara sukarela pada Formulir 4.
J
Lainnya (disertai dengan catatan kaki yang menjelaskan transaksi tersebut)
